This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 82 arm-level events and 14 clinical features across 882 patients, 419 significant findings detected with Q value < 0.25.
-
1p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
1q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
2p gain cnv correlated to 'PATHOLOGY_N_STAGE' and 'HISTOLOGICAL_TYPE'.
-
2q gain cnv correlated to 'PATHOLOGY_N_STAGE' and 'HISTOLOGICAL_TYPE'.
-
3p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
3q gain cnv correlated to 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
4p gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
4q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
5p gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
5q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
6p gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
6q gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
7p gain cnv correlated to 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
7q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
8p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
8q gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
9p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
9q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
10p gain cnv correlated to 'PATHOLOGY_T_STAGE' and 'PATHOLOGY_N_STAGE'.
-
10q gain cnv correlated to 'PATHOLOGY_T_STAGE' and 'PATHOLOGY_N_STAGE'.
-
11p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'NUMBER_PACK_YEARS_SMOKED'.
-
11q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
12p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
12q gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
13q gain cnv correlated to 'Time to Death', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
-
14q gain cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
15q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
16p gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
16q gain cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
17p gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
-
17q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
-
18p gain cnv correlated to 'Time to Death', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
18q gain cnv correlated to 'Time to Death', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
19p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
19q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
20p gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
20q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
21q gain cnv correlated to 'KARNOFSKY_PERFORMANCE_SCORE' and 'RACE'.
-
22q gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
xp gain cnv correlated to 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
xq gain cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
1p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
1q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
2p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
2q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
3p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
3q loss cnv correlated to 'YEARS_TO_BIRTH', 'GENDER', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
4p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
4q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
5p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'ETHNICITY'.
-
5q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'ETHNICITY'.
-
6p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
6q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
7p loss cnv correlated to 'Time to Death' and 'PATHOLOGY_N_STAGE'.
-
7q loss cnv correlated to 'Time to Death' and 'PATHOLOGY_N_STAGE'.
-
8p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
8q loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
9p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
9q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
10p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
10q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
11p loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
11q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
12p loss cnv correlated to 'PATHOLOGY_N_STAGE'.
-
12q loss cnv correlated to 'PATHOLOGY_T_STAGE'.
-
13q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', and 'HISTOLOGICAL_TYPE'.
-
14q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
15q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
16p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
16q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
17p loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
17q loss cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
18p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
18q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'RACE'.
-
19p loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
19q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
20p loss cnv correlated to 'HISTOLOGICAL_TYPE'.
-
20q loss cnv correlated to 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
21q loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
22q loss cnv correlated to 'Time to Death', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
xp loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
xq loss cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGIC_STAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
PATHOLOGIC STAGE |
PATHOLOGY T STAGE |
PATHOLOGY N STAGE |
PATHOLOGY M STAGE |
GENDER |
RADIATION THERAPY |
KARNOFSKY PERFORMANCE SCORE |
HISTOLOGICAL TYPE |
NUMBER PACK YEARS SMOKED |
YEAR OF TOBACCO SMOKING ONSET |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Wilcoxon-test | Fisher's exact test | Wilcoxon-test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | |
12q gain | 256 (29%) | 626 |
0.0708 (0.205) |
0.25 (0.484) |
0.0337 (0.119) |
0.0669 (0.196) |
0.00279 (0.0155) |
0.013 (0.0538) |
0.00574 (0.0284) |
1 (1.00) |
0.0571 (0.175) |
1e-05 (0.000118) |
0.992 (1.00) |
0.309 (0.546) |
0.905 (1.00) |
0.0557 (0.174) |
17p gain | 196 (22%) | 686 |
0.0122 (0.0509) |
0.604 (0.843) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.0184 (0.0718) |
0.01 (0.0438) |
0.000289 (0.00222) |
1 (1.00) |
0.611 (0.848) |
1e-05 (0.000118) |
0.781 (0.989) |
0.0967 (0.257) |
0.00884 (0.0395) |
0.0104 (0.0447) |
5p loss | 24 (3%) | 858 |
0.0571 (0.175) |
0.0017 (0.00996) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.0176 (0.069) |
0.261 (0.499) |
0.0816 (0.228) |
1 (1.00) |
0.247 (0.481) |
2e-05 (0.000201) |
0.0793 (0.224) |
0.333 (0.578) |
0.365 (0.607) |
0.086 (0.239) |
9p loss | 192 (22%) | 690 |
3.48e-12 (2e-09) |
0.078 (0.221) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00318 (0.0171) |
0.000125 (0.00106) |
0.261 (0.499) |
0.378 (0.618) |
0.00183 (0.0106) |
1e-05 (0.000118) |
0.796 (0.997) |
0.893 (1.00) |
0.014 (0.057) |
0.561 (0.801) |
9q loss | 195 (22%) | 687 |
5.03e-10 (1.44e-07) |
0.0619 (0.184) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.0113 (0.0478) |
0.00159 (0.00953) |
0.197 (0.416) |
0.378 (0.618) |
0.00118 (0.00743) |
1e-05 (0.000118) |
0.974 (1.00) |
0.719 (0.936) |
0.0115 (0.0483) |
1 (1.00) |
14q loss | 265 (30%) | 617 |
1.07e-09 (2.47e-07) |
0.291 (0.532) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00607 (0.0297) |
4.11e-05 (0.00038) |
0.815 (1.00) |
0.0959 (0.257) |
0.000194 (0.00158) |
1e-05 (0.000118) |
0.264 (0.503) |
0.00516 (0.0258) |
0.0208 (0.0797) |
0.864 (1.00) |
22q loss | 107 (12%) | 775 |
0.00104 (0.00677) |
0.63 (0.858) |
1e-05 (0.000118) |
0.00033 (0.00248) |
1e-05 (0.000118) |
0.0269 (0.0985) |
0.0279 (0.102) |
1 (1.00) |
0.00464 (0.0235) |
1e-05 (0.000118) |
0.899 (1.00) |
0.325 (0.57) |
0.588 (0.829) |
0.0281 (0.102) |
17q gain | 222 (25%) | 660 |
0.146 (0.338) |
0.335 (0.58) |
2e-05 (0.000201) |
7e-05 (0.000609) |
0.00356 (0.0191) |
0.0451 (0.148) |
0.0107 (0.0456) |
1 (1.00) |
0.688 (0.913) |
1e-05 (0.000118) |
0.884 (1.00) |
0.145 (0.338) |
0.0118 (0.0496) |
0.0341 (0.12) |
1q gain | 68 (8%) | 814 |
6.31e-06 (0.000118) |
0.0416 (0.141) |
0.00018 (0.00148) |
0.00047 (0.00339) |
0.00822 (0.0377) |
0.225 (0.453) |
0.351 (0.596) |
1 (1.00) |
0.049 (0.157) |
0.00457 (0.0232) |
0.282 (0.521) |
0.103 (0.267) |
0.374 (0.614) |
0.763 (0.974) |
12p gain | 252 (29%) | 630 |
0.102 (0.266) |
0.135 (0.322) |
0.0583 (0.178) |
0.134 (0.321) |
0.00852 (0.0388) |
0.00873 (0.0391) |
0.00562 (0.0279) |
1 (1.00) |
0.0571 (0.175) |
2e-05 (0.000201) |
0.797 (0.997) |
0.153 (0.349) |
0.935 (1.00) |
0.0792 (0.224) |
2p loss | 65 (7%) | 817 |
0.00429 (0.0222) |
4.4e-05 (0.000404) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.16 (0.36) |
0.0701 (0.204) |
0.135 (0.321) |
1 (1.00) |
0.0487 (0.157) |
1e-05 (0.000118) |
0.611 (0.848) |
0.96 (1.00) |
0.228 (0.456) |
0.491 (0.729) |
2q loss | 63 (7%) | 819 |
0.00297 (0.0162) |
2.51e-05 (0.00025) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.158 (0.357) |
0.0701 (0.204) |
0.166 (0.365) |
1 (1.00) |
0.0487 (0.157) |
1e-05 (0.000118) |
0.331 (0.578) |
0.96 (1.00) |
0.14 (0.33) |
0.491 (0.729) |
3p loss | 411 (47%) | 471 |
0.00287 (0.0157) |
0.818 (1.00) |
0.00055 (0.00385) |
2e-05 (0.000201) |
0.0729 (0.21) |
0.817 (1.00) |
0.775 (0.984) |
0.214 (0.44) |
0.0942 (0.254) |
1e-05 (0.000118) |
0.333 (0.578) |
0.0264 (0.0973) |
0.00072 (0.00483) |
0.428 (0.665) |
4p loss | 98 (11%) | 784 |
2.36e-11 (9.05e-09) |
0.374 (0.614) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00158 (0.00953) |
0.0145 (0.0588) |
0.0538 (0.17) |
1 (1.00) |
0.157 (0.355) |
0.00192 (0.0111) |
0.976 (1.00) |
0.223 (0.451) |
0.131 (0.316) |
0.447 (0.68) |
5q loss | 23 (3%) | 859 |
0.22 (0.448) |
0.000448 (0.00328) |
8e-05 (0.000691) |
4e-05 (0.000373) |
0.0488 (0.157) |
1 (1.00) |
0.176 (0.381) |
1 (1.00) |
0.859 (1.00) |
1e-05 (0.000118) |
0.037 (0.128) |
0.128 (0.312) |
0.47 (0.705) |
0.074 (0.213) |
11q loss | 52 (6%) | 830 |
0.000746 (0.00498) |
0.0151 (0.0605) |
4e-05 (0.000373) |
4e-05 (0.000373) |
2e-05 (0.000201) |
0.314 (0.552) |
0.547 (0.789) |
1 (1.00) |
0.0432 (0.144) |
0.0317 (0.114) |
0.536 (0.778) |
0.242 (0.475) |
0.359 (0.605) |
0.723 (0.937) |
13q loss | 137 (16%) | 745 |
0.0341 (0.12) |
0.00011 (0.000942) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00757 (0.0353) |
0.115 (0.293) |
0.0137 (0.0563) |
1 (1.00) |
0.638 (0.865) |
1e-05 (0.000118) |
0.933 (1.00) |
0.6 (0.84) |
0.163 (0.362) |
0.641 (0.868) |
15q loss | 68 (8%) | 814 |
1.98e-05 (0.000201) |
0.418 (0.655) |
2e-05 (0.000201) |
2e-05 (0.000201) |
0.00243 (0.0137) |
0.0139 (0.0567) |
0.592 (0.833) |
1 (1.00) |
0.0746 (0.213) |
0.0668 (0.196) |
0.354 (0.599) |
0.307 (0.546) |
0.352 (0.596) |
|
17q loss | 82 (9%) | 800 |
0.00889 (0.0396) |
0.000456 (0.00331) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.12 (0.3) |
0.557 (0.798) |
0.538 (0.78) |
1 (1.00) |
0.0283 (0.102) |
1e-05 (0.000118) |
0.611 (0.848) |
0.963 (1.00) |
0.0654 (0.193) |
0.523 (0.763) |
5p gain | 238 (27%) | 644 |
0.39 (0.629) |
0.000654 (0.00444) |
0.00031 (0.00234) |
0.00028 (0.00219) |
0.912 (1.00) |
0.18 (0.386) |
0.0906 (0.249) |
0.469 (0.705) |
0.11 (0.282) |
1e-05 (0.000118) |
0.88 (1.00) |
0.948 (1.00) |
0.00026 (0.00206) |
0.857 (1.00) |
8q gain | 103 (12%) | 779 |
0.00853 (0.0388) |
0.132 (0.317) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00393 (0.0207) |
0.0124 (0.0517) |
0.911 (1.00) |
1 (1.00) |
0.308 (0.546) |
0.00133 (0.00825) |
0.359 (0.605) |
0.253 (0.487) |
0.154 (0.35) |
1 (1.00) |
11q gain | 55 (6%) | 827 |
0.247 (0.481) |
0.0524 (0.166) |
0.0346 (0.121) |
0.00897 (0.0396) |
0.497 (0.735) |
0.159 (0.357) |
0.3 (0.543) |
0.216 (0.443) |
0.149 (0.343) |
1e-05 (0.000118) |
0.0422 (0.142) |
0.0498 (0.159) |
0.35 (0.596) |
0.309 (0.546) |
20p gain | 233 (26%) | 649 |
0.405 (0.646) |
0.43 (0.665) |
0.00872 (0.0391) |
0.00374 (0.0199) |
0.0618 (0.184) |
0.0461 (0.151) |
0.00114 (0.00728) |
0.199 (0.417) |
0.849 (1.00) |
0.00022 (0.00175) |
0.206 (0.427) |
0.67 (0.893) |
0.307 (0.546) |
0.365 (0.607) |
20q gain | 237 (27%) | 645 |
0.261 (0.499) |
0.25 (0.484) |
0.00751 (0.0352) |
0.00729 (0.0344) |
0.0202 (0.0777) |
0.0651 (0.192) |
0.00282 (0.0156) |
0.199 (0.417) |
0.849 (1.00) |
0.00014 (0.00117) |
0.269 (0.507) |
0.764 (0.975) |
0.157 (0.355) |
0.284 (0.522) |
xp gain | 129 (15%) | 753 |
0.141 (0.331) |
0.179 (0.385) |
0.0343 (0.12) |
0.0614 (0.184) |
1 (1.00) |
0.25 (0.484) |
0.00608 (0.0297) |
1 (1.00) |
0.108 (0.277) |
1e-05 (0.000118) |
0.418 (0.655) |
0.057 (0.175) |
0.033 (0.117) |
0.661 (0.888) |
xq gain | 130 (15%) | 752 |
0.0762 (0.217) |
0.27 (0.507) |
0.0643 (0.19) |
0.113 (0.289) |
1 (1.00) |
0.178 (0.383) |
0.00859 (0.0388) |
1 (1.00) |
0.074 (0.213) |
1e-05 (0.000118) |
0.653 (0.879) |
0.165 (0.365) |
0.0226 (0.0862) |
0.662 (0.888) |
1q loss | 110 (12%) | 772 |
0.0236 (0.0896) |
0.00104 (0.00677) |
3e-05 (0.000289) |
0.00015 (0.00124) |
0.488 (0.728) |
0.0522 (0.166) |
0.235 (0.466) |
1 (1.00) |
0.557 (0.798) |
1e-05 (0.000118) |
0.445 (0.68) |
0.96 (1.00) |
0.248 (0.481) |
0.125 (0.309) |
4q loss | 92 (10%) | 790 |
6.76e-13 (7.76e-10) |
0.47 (0.706) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00116 (0.00736) |
0.000606 (0.00422) |
0.414 (0.651) |
1 (1.00) |
0.136 (0.322) |
0.00855 (0.0388) |
0.886 (1.00) |
0.162 (0.361) |
0.0938 (0.254) |
0.602 (0.84) |
6p loss | 171 (19%) | 711 |
0.636 (0.865) |
0.0574 (0.176) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.0542 (0.17) |
0.782 (0.989) |
0.528 (0.769) |
1 (1.00) |
0.174 (0.378) |
1e-05 (0.000118) |
0.367 (0.609) |
0.701 (0.922) |
0.00039 (0.00289) |
0.672 (0.894) |
6q loss | 206 (23%) | 676 |
0.097 (0.257) |
0.0567 (0.175) |
3e-05 (0.000289) |
2e-05 (0.000201) |
0.0442 (0.147) |
0.896 (1.00) |
0.554 (0.796) |
1 (1.00) |
0.279 (0.518) |
1e-05 (0.000118) |
0.142 (0.333) |
0.639 (0.866) |
0.0007 (0.00473) |
0.332 (0.578) |
8p loss | 161 (18%) | 721 |
0.0148 (0.0596) |
0.811 (1.00) |
0.0324 (0.115) |
0.0371 (0.128) |
0.674 (0.895) |
0.0402 (0.137) |
0.459 (0.694) |
1 (1.00) |
0.767 (0.977) |
1e-05 (0.000118) |
0.957 (1.00) |
0.666 (0.892) |
0.0321 (0.115) |
0.138 (0.326) |
11p loss | 42 (5%) | 840 |
0.00759 (0.0353) |
0.0463 (0.151) |
0.00142 (0.00867) |
0.00113 (0.00725) |
0.00063 (0.00436) |
0.393 (0.631) |
0.738 (0.953) |
1 (1.00) |
0.372 (0.613) |
0.0194 (0.0752) |
0.939 (1.00) |
0.125 (0.308) |
0.499 (0.736) |
0.247 (0.481) |
18p loss | 141 (16%) | 741 |
5.07e-08 (8.31e-06) |
0.533 (0.776) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.0152 (0.0605) |
0.0239 (0.0903) |
1 (1.00) |
1 (1.00) |
0.275 (0.513) |
0.285 (0.523) |
0.176 (0.382) |
0.073 (0.21) |
0.101 (0.264) |
0.181 (0.387) |
18q loss | 148 (17%) | 734 |
5.6e-07 (8.03e-05) |
0.553 (0.796) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.00366 (0.0195) |
0.0378 (0.13) |
1 (1.00) |
1 (1.00) |
0.344 (0.588) |
0.499 (0.736) |
0.304 (0.546) |
0.152 (0.347) |
0.059 (0.179) |
0.129 (0.314) |
19q loss | 23 (3%) | 859 |
0.000207 (0.00167) |
0.19 (0.402) |
0.00031 (0.00234) |
2e-05 (0.000201) |
5e-05 (0.000452) |
0.0881 (0.243) |
0.826 (1.00) |
1 (1.00) |
0.247 (0.481) |
0.0005 (0.00357) |
0.392 (0.631) |
0.18 (0.386) |
0.341 (0.584) |
1 (1.00) |
21q loss | 133 (15%) | 749 |
0.89 (1.00) |
0.0543 (0.17) |
0.00051 (0.00361) |
1e-05 (0.000118) |
0.00165 (0.00976) |
1 (1.00) |
0.426 (0.662) |
1 (1.00) |
0.183 (0.391) |
1e-05 (0.000118) |
0.447 (0.68) |
0.0566 (0.175) |
0.119 (0.299) |
0.496 (0.733) |
1p gain | 31 (4%) | 851 |
1.03e-08 (1.97e-06) |
0.0808 (0.227) |
0.00278 (0.0155) |
0.00603 (0.0297) |
0.00698 (0.0332) |
0.117 (0.297) |
0.561 (0.801) |
1 (1.00) |
0.1 (0.263) |
0.515 (0.754) |
1 (1.00) |
0.392 (0.631) |
0.389 (0.629) |
|
3p gain | 103 (12%) | 779 |
0.806 (1.00) |
0.138 (0.326) |
0.0268 (0.0985) |
0.0155 (0.0615) |
0.0165 (0.0652) |
1 (1.00) |
0.12 (0.3) |
1 (1.00) |
0.0893 (0.246) |
1e-05 (0.000118) |
0.882 (1.00) |
0.472 (0.707) |
0.369 (0.609) |
0.809 (1.00) |
5q gain | 253 (29%) | 629 |
0.551 (0.794) |
0.00195 (0.0112) |
0.00144 (0.00875) |
0.00634 (0.0307) |
0.698 (0.918) |
0.189 (0.402) |
0.0968 (0.257) |
0.507 (0.744) |
0.132 (0.317) |
1e-05 (0.000118) |
0.719 (0.936) |
0.869 (1.00) |
0.00088 (0.00584) |
1 (1.00) |
7q gain | 371 (42%) | 511 |
0.912 (1.00) |
0.224 (0.452) |
0.0635 (0.188) |
0.973 (1.00) |
0.203 (0.422) |
0.00437 (0.0224) |
8.05e-07 (9.25e-05) |
0.0949 (0.256) |
0.563 (0.802) |
1e-05 (0.000118) |
0.408 (0.646) |
0.00638 (0.0307) |
0.143 (0.333) |
0.421 (0.658) |
9p gain | 26 (3%) | 856 |
0.153 (0.349) |
0.614 (0.849) |
0.00315 (0.0171) |
0.00163 (0.0097) |
0.292 (0.533) |
0.0581 (0.177) |
0.0101 (0.0441) |
1 (1.00) |
0.0927 (0.252) |
2e-05 (0.000201) |
0.298 (0.541) |
0.394 (0.632) |
0.388 (0.629) |
|
11p gain | 58 (7%) | 824 |
0.714 (0.934) |
0.159 (0.357) |
0.00425 (0.0221) |
0.00131 (0.00817) |
0.224 (0.453) |
0.0371 (0.128) |
0.665 (0.891) |
0.21 (0.433) |
0.36 (0.605) |
2e-05 (0.000201) |
0.0422 (0.142) |
0.152 (0.347) |
0.34 (0.584) |
0.34 (0.584) |
14q gain | 39 (4%) | 843 |
0.775 (0.984) |
0.0426 (0.143) |
0.00141 (0.00866) |
0.0004 (0.00294) |
0.365 (0.607) |
0.584 (0.825) |
0.488 (0.728) |
1 (1.00) |
0.229 (0.457) |
1e-05 (0.000118) |
0.1 (0.263) |
0.084 (0.235) |
0.242 (0.475) |
0.668 (0.892) |
16p gain | 281 (32%) | 601 |
0.0201 (0.0776) |
0.0129 (0.0533) |
0.851 (1.00) |
0.884 (1.00) |
0.409 (0.646) |
0.896 (1.00) |
0.00212 (0.0121) |
0.562 (0.801) |
0.813 (1.00) |
1e-05 (0.000118) |
0.979 (1.00) |
0.309 (0.546) |
0.0379 (0.13) |
0.613 (0.849) |
19p gain | 74 (8%) | 808 |
0.962 (1.00) |
0.708 (0.928) |
2e-05 (0.000201) |
3e-05 (0.000289) |
0.161 (0.36) |
0.0107 (0.0457) |
0.606 (0.844) |
0.216 (0.443) |
0.972 (1.00) |
1e-05 (0.000118) |
0.407 (0.646) |
0.126 (0.309) |
0.00161 (0.00963) |
1 (1.00) |
19q gain | 78 (9%) | 804 |
0.743 (0.955) |
0.776 (0.984) |
2e-05 (0.000201) |
4e-05 (0.000373) |
0.743 (0.955) |
0.00274 (0.0153) |
0.706 (0.927) |
0.204 (0.423) |
0.972 (1.00) |
1e-05 (0.000118) |
0.731 (0.945) |
0.202 (0.421) |
0.00064 (0.00437) |
1 (1.00) |
3q loss | 119 (13%) | 763 |
0.28 (0.519) |
0.0451 (0.148) |
0.152 (0.347) |
0.0984 (0.26) |
0.123 (0.306) |
0.54 (0.781) |
0.0358 (0.125) |
0.0158 (0.0624) |
0.725 (0.939) |
1e-05 (0.000118) |
0.06 (0.181) |
0.614 (0.849) |
||
16p loss | 18 (2%) | 864 |
6.56e-06 (0.000118) |
0.978 (1.00) |
0.00896 (0.0396) |
0.00029 (0.00222) |
0.00097 (0.00636) |
0.702 (0.922) |
0.617 (0.849) |
1 (1.00) |
0.0686 (0.2) |
1 (1.00) |
1 (1.00) |
|||
17p loss | 111 (13%) | 771 |
0.626 (0.854) |
0.00397 (0.0208) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.0005 (0.00357) |
0.169 (0.371) |
0.281 (0.519) |
1 (1.00) |
0.436 (0.672) |
1e-05 (0.000118) |
0.86 (1.00) |
0.837 (1.00) |
0.341 (0.584) |
1 (1.00) |
19p loss | 29 (3%) | 853 |
5.51e-05 (0.000495) |
0.226 (0.454) |
0.0012 (0.00753) |
0.00064 (0.00437) |
0.025 (0.0927) |
0.146 (0.338) |
0.844 (1.00) |
1 (1.00) |
0.247 (0.481) |
0.043 (0.143) |
0.581 (0.822) |
0.49 (0.729) |
1 (1.00) |
|
xp loss | 114 (13%) | 768 |
0.475 (0.709) |
0.000515 (0.00363) |
0.00022 (0.00175) |
6e-05 (0.00053) |
0.00384 (0.0203) |
1 (1.00) |
0.135 (0.322) |
1 (1.00) |
0.521 (0.761) |
1e-05 (0.000118) |
0.697 (0.918) |
0.447 (0.68) |
0.389 (0.629) |
0.303 (0.546) |
xq loss | 113 (13%) | 769 |
0.2 (0.417) |
0.00171 (0.00996) |
0.00039 (0.00289) |
0.00015 (0.00124) |
0.00634 (0.0307) |
0.863 (1.00) |
0.24 (0.474) |
1 (1.00) |
0.241 (0.475) |
1e-05 (0.000118) |
0.986 (1.00) |
0.848 (1.00) |
0.167 (0.367) |
0.3 (0.543) |
3q gain | 161 (18%) | 721 |
0.301 (0.543) |
0.127 (0.311) |
0.334 (0.578) |
0.152 (0.347) |
0.0242 (0.091) |
0.0995 (0.262) |
0.026 (0.0963) |
1 (1.00) |
0.492 (0.73) |
1e-05 (0.000118) |
0.861 (1.00) |
0.446 (0.68) |
0.0803 (0.226) |
0.84 (1.00) |
4p gain | 47 (5%) | 835 |
0.601 (0.84) |
0.0249 (0.0927) |
0.0045 (0.023) |
0.0072 (0.0342) |
0.127 (0.311) |
0.584 (0.825) |
1 (1.00) |
1 (1.00) |
0.723 (0.937) |
1e-05 (0.000118) |
0.162 (0.361) |
0.236 (0.467) |
0.304 (0.546) |
0.457 (0.693) |
4q gain | 46 (5%) | 836 |
0.273 (0.51) |
0.0416 (0.141) |
0.0112 (0.0475) |
0.0208 (0.0797) |
0.097 (0.257) |
0.784 (0.992) |
0.872 (1.00) |
1 (1.00) |
0.79 (0.995) |
1e-05 (0.000118) |
0.305 (0.546) |
0.236 (0.467) |
0.337 (0.581) |
0.437 (0.674) |
6p gain | 22 (2%) | 860 |
0.0601 (0.181) |
0.718 (0.936) |
0.00137 (0.00846) |
0.00256 (0.0144) |
0.004 (0.0209) |
0.119 (0.299) |
0.364 (0.607) |
1 (1.00) |
0.789 (0.995) |
0.305 (0.546) |
0.958 (1.00) |
0.792 (0.995) |
0.715 (0.935) |
0.616 (0.849) |
6q gain | 16 (2%) | 866 |
0.00434 (0.0223) |
0.907 (1.00) |
0.0244 (0.0913) |
0.0106 (0.0456) |
0.0397 (0.136) |
0.191 (0.402) |
0.599 (0.84) |
1 (1.00) |
0.789 (0.995) |
0.668 (0.892) |
0.352 (0.596) |
0.622 (0.852) |
0.8 (0.999) |
1 (1.00) |
7p gain | 369 (42%) | 513 |
0.572 (0.812) |
0.19 (0.402) |
0.221 (0.449) |
0.969 (1.00) |
0.213 (0.438) |
0.0242 (0.091) |
7.47e-07 (9.25e-05) |
0.593 (0.834) |
0.402 (0.643) |
1e-05 (0.000118) |
0.369 (0.609) |
0.00638 (0.0307) |
0.198 (0.417) |
0.421 (0.658) |
8p gain | 69 (8%) | 813 |
0.389 (0.629) |
0.494 (0.731) |
2e-05 (0.000201) |
2e-05 (0.000201) |
0.0545 (0.17) |
0.502 (0.737) |
1 (1.00) |
1 (1.00) |
0.792 (0.995) |
7e-05 (0.000609) |
0.964 (1.00) |
0.321 (0.564) |
0.284 (0.522) |
1 (1.00) |
9q gain | 24 (3%) | 858 |
0.454 (0.689) |
0.671 (0.893) |
0.00113 (0.00725) |
0.00012 (0.00102) |
0.293 (0.534) |
1 (1.00) |
0.0449 (0.148) |
1 (1.00) |
0.0927 (0.252) |
3e-05 (0.000289) |
0.298 (0.541) |
0.229 (0.457) |
0.365 (0.607) |
|
15q gain | 52 (6%) | 830 |
0.264 (0.502) |
0.338 (0.583) |
0.00095 (0.00627) |
0.00311 (0.0169) |
0.462 (0.696) |
0.474 (0.709) |
0.649 (0.874) |
1 (1.00) |
0.924 (1.00) |
1e-05 (0.000118) |
0.418 (0.655) |
0.0588 (0.178) |
0.384 (0.626) |
0.269 (0.507) |
16q gain | 268 (30%) | 614 |
0.00215 (0.0122) |
0.0317 (0.114) |
0.409 (0.646) |
0.692 (0.915) |
0.905 (1.00) |
0.423 (0.66) |
0.0102 (0.0442) |
1 (1.00) |
0.744 (0.955) |
1e-05 (0.000118) |
0.616 (0.849) |
0.309 (0.546) |
0.0958 (0.257) |
0.864 (1.00) |
1p loss | 145 (16%) | 737 |
0.136 (0.322) |
0.0108 (0.0461) |
6e-05 (0.00053) |
5e-05 (0.000452) |
0.176 (0.381) |
0.119 (0.299) |
0.441 (0.679) |
1 (1.00) |
0.799 (0.999) |
1e-05 (0.000118) |
0.367 (0.609) |
0.253 (0.487) |
0.695 (0.918) |
0.108 (0.277) |
10p loss | 133 (15%) | 749 |
0.952 (1.00) |
0.0742 (0.213) |
1e-05 (0.000118) |
2e-05 (0.000201) |
0.0915 (0.25) |
1 (1.00) |
0.69 (0.915) |
1 (1.00) |
0.558 (0.798) |
1e-05 (0.000118) |
0.173 (0.378) |
0.448 (0.68) |
0.368 (0.609) |
0.22 (0.448) |
10q loss | 157 (18%) | 725 |
0.934 (1.00) |
0.0296 (0.107) |
1e-05 (0.000118) |
1e-05 (0.000118) |
0.256 (0.491) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.834 (1.00) |
1e-05 (0.000118) |
0.173 (0.378) |
0.448 (0.68) |
0.143 (0.333) |
0.262 (0.5) |
16q loss | 28 (3%) | 854 |
2.23e-06 (0.000118) |
0.407 (0.646) |
0.00488 (0.0245) |
0.00029 (0.00222) |
0.00028 (0.00219) |
0.72 (0.936) |
1 (1.00) |
1 (1.00) |
0.165 (0.365) |
0.112 (0.286) |
0.179 (0.385) |
0.867 (1.00) |
0.875 (1.00) |
0.621 (0.852) |
13q gain | 52 (6%) | 830 |
0.0909 (0.249) |
0.309 (0.546) |
0.865 (1.00) |
0.945 (1.00) |
0.352 (0.596) |
0.793 (0.995) |
0.13 (0.314) |
0.0148 (0.0595) |
0.759 (0.97) |
0.00483 (0.0243) |
1 (1.00) |
0.876 (1.00) |
0.891 (1.00) |
0.182 (0.387) |
18p gain | 54 (6%) | 828 |
0.00923 (0.0404) |
0.617 (0.849) |
0.501 (0.737) |
0.592 (0.833) |
1 (1.00) |
0.638 (0.865) |
0.372 (0.613) |
1 (1.00) |
0.13 (0.314) |
1e-05 (0.000118) |
0.265 (0.503) |
0.43 (0.665) |
0.0758 (0.216) |
0.291 (0.532) |
18q gain | 50 (6%) | 832 |
0.00765 (0.0353) |
0.79 (0.995) |
0.394 (0.632) |
0.429 (0.665) |
0.575 (0.815) |
0.461 (0.696) |
0.283 (0.522) |
1 (1.00) |
0.0275 (0.1) |
1e-05 (0.000118) |
0.886 (1.00) |
0.43 (0.665) |
0.102 (0.266) |
0.276 (0.513) |
22q gain | 64 (7%) | 818 |
0.572 (0.812) |
0.357 (0.603) |
0.0138 (0.0564) |
0.0017 (0.00996) |
0.125 (0.309) |
0.834 (1.00) |
0.411 (0.648) |
0.21 (0.433) |
0.988 (1.00) |
1e-05 (0.000118) |
0.716 (0.936) |
0.413 (0.65) |
0.0941 (0.254) |
0.3 (0.543) |
20q loss | 6 (1%) | 876 |
0.871 (1.00) |
0.123 (0.306) |
0.109 (0.278) |
0.165 (0.365) |
0.0873 (0.241) |
0.597 (0.838) |
1 (1.00) |
1 (1.00) |
0.00764 (0.0353) |
0.648 (0.874) |
0.0633 (0.188) |
|||
2p gain | 120 (14%) | 762 |
0.459 (0.694) |
0.332 (0.578) |
0.376 (0.616) |
0.118 (0.298) |
0.0373 (0.129) |
0.622 (0.852) |
1 (1.00) |
0.317 (0.558) |
0.146 (0.339) |
0.0188 (0.0732) |
0.185 (0.393) |
0.849 (1.00) |
0.691 (0.915) |
0.814 (1.00) |
2q gain | 127 (14%) | 755 |
0.646 (0.874) |
0.241 (0.474) |
0.523 (0.763) |
0.273 (0.51) |
0.017 (0.0667) |
0.747 (0.958) |
0.543 (0.784) |
0.345 (0.59) |
0.233 (0.463) |
0.00909 (0.04) |
0.336 (0.581) |
0.831 (1.00) |
0.723 (0.937) |
0.649 (0.874) |
10p gain | 28 (3%) | 854 |
0.92 (1.00) |
0.758 (0.97) |
0.168 (0.368) |
0.00739 (0.0348) |
0.0141 (0.0572) |
1 (1.00) |
0.541 (0.782) |
1 (1.00) |
0.625 (0.854) |
0.381 (0.621) |
0.753 (0.964) |
0.147 (0.34) |
0.625 (0.854) |
|
10q gain | 22 (2%) | 860 |
0.424 (0.661) |
0.202 (0.421) |
0.267 (0.505) |
0.0465 (0.152) |
0.0238 (0.0902) |
0.74 (0.954) |
0.252 (0.486) |
1 (1.00) |
0.988 (1.00) |
0.886 (1.00) |
0.13 (0.314) |
0.616 (0.849) |
||
21q gain | 72 (8%) | 810 |
0.398 (0.638) |
0.451 (0.685) |
0.387 (0.629) |
0.221 (0.449) |
1 (1.00) |
0.405 (0.646) |
0.696 (0.918) |
1 (1.00) |
0.0417 (0.141) |
0.385 (0.627) |
0.447 (0.68) |
0.627 (0.855) |
0.0613 (0.184) |
0.77 (0.98) |
7p loss | 4 (0%) | 878 |
0.0855 (0.238) |
0.409 (0.646) |
0.269 (0.507) |
0.107 (0.277) |
0.0477 (0.155) |
1 (1.00) |
0.308 (0.546) |
1 (1.00) |
0.362 (0.607) |
1 (1.00) |
1 (1.00) |
|||
7q loss | 4 (0%) | 878 |
0.0855 (0.238) |
0.409 (0.646) |
0.27 (0.507) |
0.107 (0.277) |
0.0481 (0.155) |
1 (1.00) |
0.308 (0.546) |
1 (1.00) |
0.363 (0.607) |
1 (1.00) |
1 (1.00) |
|||
8q loss | 83 (9%) | 799 |
0.515 (0.754) |
0.205 (0.425) |
0.535 (0.777) |
0.346 (0.59) |
1 (1.00) |
1 (1.00) |
0.22 (0.448) |
1 (1.00) |
0.564 (0.802) |
1e-05 (0.000118) |
0.939 (1.00) |
0.269 (0.507) |
0.161 (0.36) |
|
12p loss | 7 (1%) | 875 |
0.124 (0.308) |
0.741 (0.955) |
0.147 (0.339) |
0.107 (0.277) |
0.0479 (0.155) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.0999 (0.263) |
1 (1.00) |
1 (1.00) |
|||
12q loss | 4 (0%) | 878 |
0.998 (1.00) |
0.333 (0.578) |
0.272 (0.509) |
0.0542 (0.17) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.174 (0.378) |
1 (1.00) |
1 (1.00) |
||||
20p loss | 12 (1%) | 870 |
0.444 (0.68) |
0.229 (0.457) |
0.116 (0.295) |
0.129 (0.314) |
0.0965 (0.257) |
0.658 (0.885) |
0.226 (0.454) |
1 (1.00) |
0.00678 (0.0324) |
0.131 (0.316) |
0.279 (0.518) |
P value = 1.03e-08 (logrank test), Q value = 2e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
1P GAIN MUTATED | 31 | 20 | 0.5 - 118.8 (22.3) |
1P GAIN WILD-TYPE | 845 | 208 | 0.1 - 194.8 (36.5) |
P value = 0.0808 (Wilcoxon-test), Q value = 0.23
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
1P GAIN MUTATED | 29 | 63.1 (12.6) |
1P GAIN WILD-TYPE | 847 | 60.0 (12.5) |
P value = 0.00278 (Fisher's exact test), Q value = 0.015
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
1P GAIN MUTATED | 7 | 4 | 13 | 6 |
1P GAIN WILD-TYPE | 447 | 99 | 177 | 98 |
P value = 0.00603 (Fisher's exact test), Q value = 0.03
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
1P GAIN MUTATED | 9 | 4 | 18 | 0 |
1P GAIN WILD-TYPE | 471 | 123 | 240 | 15 |
P value = 0.00698 (Fisher's exact test), Q value = 0.033
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
1P GAIN MUTATED | 11 | 6 | 1 |
1P GAIN WILD-TYPE | 312 | 38 | 5 |
P value = 6.31e-06 (logrank test), Q value = 0.00012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
1Q GAIN MUTATED | 68 | 32 | 0.4 - 129.4 (24.8) |
1Q GAIN WILD-TYPE | 808 | 196 | 0.1 - 194.8 (36.7) |
P value = 0.0416 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
1Q GAIN MUTATED | 66 | 62.7 (12.1) |
1Q GAIN WILD-TYPE | 810 | 59.9 (12.5) |
P value = 0.00018 (Fisher's exact test), Q value = 0.0015
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
1Q GAIN MUTATED | 20 | 8 | 27 | 12 |
1Q GAIN WILD-TYPE | 434 | 95 | 163 | 92 |
P value = 0.00047 (Fisher's exact test), Q value = 0.0034
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
1Q GAIN MUTATED | 23 | 10 | 35 | 0 |
1Q GAIN WILD-TYPE | 457 | 117 | 223 | 15 |
P value = 0.00822 (Fisher's exact test), Q value = 0.038
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
1Q GAIN MUTATED | 27 | 9 | 2 |
1Q GAIN WILD-TYPE | 296 | 35 | 4 |
P value = 0.049 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
1Q GAIN MUTATED | 11 | 60.0 (47.7) |
1Q GAIN WILD-TYPE | 132 | 90.0 (17.8) |
P value = 0.00457 (Fisher's exact test), Q value = 0.023
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
1Q GAIN MUTATED | 0 | 50 | 18 |
1Q GAIN WILD-TYPE | 66 | 478 | 270 |
P value = 0.0373 (Fisher's exact test), Q value = 0.13
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
2P GAIN MUTATED | 43 | 11 | 2 |
2P GAIN WILD-TYPE | 280 | 33 | 4 |
P value = 0.0188 (Fisher's exact test), Q value = 0.073
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
2P GAIN MUTATED | 2 | 76 | 42 |
2P GAIN WILD-TYPE | 64 | 452 | 246 |
P value = 0.017 (Fisher's exact test), Q value = 0.067
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
2Q GAIN MUTATED | 45 | 11 | 3 |
2Q GAIN WILD-TYPE | 278 | 33 | 3 |
P value = 0.00909 (Fisher's exact test), Q value = 0.04
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
2Q GAIN MUTATED | 2 | 78 | 47 |
2Q GAIN WILD-TYPE | 64 | 450 | 241 |
P value = 0.0268 (Fisher's exact test), Q value = 0.098
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
3P GAIN MUTATED | 57 | 16 | 11 | 11 |
3P GAIN WILD-TYPE | 397 | 87 | 179 | 93 |
P value = 0.0155 (Fisher's exact test), Q value = 0.061
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
3P GAIN MUTATED | 61 | 20 | 18 | 3 |
3P GAIN WILD-TYPE | 419 | 107 | 240 | 12 |
P value = 0.0165 (Fisher's exact test), Q value = 0.065
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
3P GAIN MUTATED | 20 | 8 | 1 |
3P GAIN WILD-TYPE | 303 | 36 | 5 |
P value = 0.0893 (Wilcoxon-test), Q value = 0.25
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
3P GAIN MUTATED | 26 | 94.6 (8.1) |
3P GAIN WILD-TYPE | 117 | 86.2 (24.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
3P GAIN MUTATED | 9 | 19 | 75 |
3P GAIN WILD-TYPE | 57 | 509 | 213 |
P value = 0.0242 (Fisher's exact test), Q value = 0.091
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
3Q GAIN MUTATED | 44 | 13 | 1 |
3Q GAIN WILD-TYPE | 279 | 31 | 5 |
P value = 0.026 (Fisher's exact test), Q value = 0.096
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
3Q GAIN MUTATED | 41 | 120 |
3Q GAIN WILD-TYPE | 251 | 470 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
3Q GAIN MUTATED | 9 | 58 | 94 |
3Q GAIN WILD-TYPE | 57 | 470 | 194 |
P value = 0.0803 (Fisher's exact test), Q value = 0.23
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
3Q GAIN MUTATED | 2 | 2 | 20 | 128 |
3Q GAIN WILD-TYPE | 0 | 14 | 101 | 591 |
P value = 0.0249 (Wilcoxon-test), Q value = 0.093
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
4P GAIN MUTATED | 46 | 56.3 (13.3) |
4P GAIN WILD-TYPE | 830 | 60.4 (12.4) |
P value = 0.0045 (Fisher's exact test), Q value = 0.023
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
4P GAIN MUTATED | 18 | 13 | 7 | 8 |
4P GAIN WILD-TYPE | 436 | 90 | 183 | 96 |
P value = 0.0072 (Fisher's exact test), Q value = 0.034
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
4P GAIN MUTATED | 18 | 14 | 13 | 2 |
4P GAIN WILD-TYPE | 462 | 113 | 245 | 13 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
4P GAIN MUTATED | 24 | 13 | 10 |
4P GAIN WILD-TYPE | 42 | 515 | 278 |
P value = 0.0416 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
4Q GAIN MUTATED | 45 | 56.6 (13.3) |
4Q GAIN WILD-TYPE | 831 | 60.3 (12.5) |
P value = 0.0112 (Fisher's exact test), Q value = 0.047
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
4Q GAIN MUTATED | 19 | 13 | 7 | 6 |
4Q GAIN WILD-TYPE | 435 | 90 | 183 | 98 |
P value = 0.0208 (Fisher's exact test), Q value = 0.08
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
4Q GAIN MUTATED | 19 | 14 | 12 | 1 |
4Q GAIN WILD-TYPE | 461 | 113 | 246 | 14 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
4Q GAIN MUTATED | 24 | 13 | 9 |
4Q GAIN WILD-TYPE | 42 | 515 | 279 |
P value = 0.000654 (Wilcoxon-test), Q value = 0.0044
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
5P GAIN MUTATED | 236 | 62.7 (12.3) |
5P GAIN WILD-TYPE | 640 | 59.2 (12.5) |
P value = 0.00031 (Fisher's exact test), Q value = 0.0023
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
5P GAIN MUTATED | 102 | 25 | 66 | 42 |
5P GAIN WILD-TYPE | 352 | 78 | 124 | 62 |
P value = 0.00028 (Fisher's exact test), Q value = 0.0022
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
5P GAIN MUTATED | 106 | 33 | 92 | 7 |
5P GAIN WILD-TYPE | 374 | 94 | 166 | 8 |
P value = 0.0906 (Fisher's exact test), Q value = 0.25
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
5P GAIN MUTATED | 68 | 170 |
5P GAIN WILD-TYPE | 224 | 420 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
5P GAIN MUTATED | 8 | 195 | 35 |
5P GAIN WILD-TYPE | 58 | 333 | 253 |
P value = 0.00026 (Fisher's exact test), Q value = 0.0021
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
5P GAIN MUTATED | 0 | 4 | 15 | 214 |
5P GAIN WILD-TYPE | 2 | 12 | 106 | 505 |
P value = 0.00195 (Wilcoxon-test), Q value = 0.011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
5Q GAIN MUTATED | 250 | 62.4 (12.4) |
5Q GAIN WILD-TYPE | 626 | 59.3 (12.5) |
P value = 0.00144 (Fisher's exact test), Q value = 0.0087
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
5Q GAIN MUTATED | 115 | 25 | 66 | 44 |
5Q GAIN WILD-TYPE | 339 | 78 | 124 | 60 |
P value = 0.00634 (Fisher's exact test), Q value = 0.031
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
5Q GAIN MUTATED | 120 | 33 | 94 | 6 |
5Q GAIN WILD-TYPE | 360 | 94 | 164 | 9 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
5Q GAIN MUTATED | 8 | 213 | 32 |
5Q GAIN WILD-TYPE | 58 | 315 | 256 |
P value = 0.00088 (Fisher's exact test), Q value = 0.0058
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
5Q GAIN MUTATED | 0 | 4 | 18 | 226 |
5Q GAIN WILD-TYPE | 2 | 12 | 103 | 493 |
P value = 0.0601 (logrank test), Q value = 0.18
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
6P GAIN MUTATED | 22 | 9 | 1.0 - 113.5 (27.7) |
6P GAIN WILD-TYPE | 854 | 219 | 0.1 - 194.8 (36.0) |
P value = 0.00137 (Fisher's exact test), Q value = 0.0085
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
6P GAIN MUTATED | 6 | 0 | 10 | 6 |
6P GAIN WILD-TYPE | 448 | 103 | 180 | 98 |
P value = 0.00256 (Fisher's exact test), Q value = 0.014
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
6P GAIN MUTATED | 6 | 1 | 14 | 1 |
6P GAIN WILD-TYPE | 474 | 126 | 244 | 14 |
P value = 0.004 (Fisher's exact test), Q value = 0.021
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
6P GAIN MUTATED | 7 | 6 | 0 |
6P GAIN WILD-TYPE | 316 | 38 | 6 |
P value = 0.00434 (logrank test), Q value = 0.022
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
6Q GAIN MUTATED | 16 | 8 | 6.4 - 113.5 (27.7) |
6Q GAIN WILD-TYPE | 860 | 220 | 0.1 - 194.8 (36.0) |
P value = 0.0244 (Fisher's exact test), Q value = 0.091
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
6Q GAIN MUTATED | 5 | 0 | 7 | 4 |
6Q GAIN WILD-TYPE | 449 | 103 | 183 | 100 |
P value = 0.0106 (Fisher's exact test), Q value = 0.046
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
6Q GAIN MUTATED | 5 | 0 | 11 | 0 |
6Q GAIN WILD-TYPE | 475 | 127 | 247 | 15 |
P value = 0.0397 (Fisher's exact test), Q value = 0.14
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
6Q GAIN MUTATED | 6 | 4 | 0 |
6Q GAIN WILD-TYPE | 317 | 40 | 6 |
P value = 0.0242 (Fisher's exact test), Q value = 0.091
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
7P GAIN MUTATED | 193 | 43 |
7P GAIN WILD-TYPE | 353 | 46 |
P value = 7.47e-07 (Fisher's exact test), Q value = 9.2e-05
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
7P GAIN MUTATED | 88 | 281 |
7P GAIN WILD-TYPE | 204 | 309 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
7P GAIN MUTATED | 24 | 173 | 172 |
7P GAIN WILD-TYPE | 42 | 355 | 116 |
P value = 0.00638 (Wilcoxon-test), Q value = 0.031
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
7P GAIN MUTATED | 38 | 1968.8 (15.1) |
7P GAIN WILD-TYPE | 36 | 1978.9 (15.5) |
P value = 0.0635 (Fisher's exact test), Q value = 0.19
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
7Q GAIN MUTATED | 191 | 39 | 69 | 54 |
7Q GAIN WILD-TYPE | 263 | 64 | 121 | 50 |
P value = 0.00437 (Fisher's exact test), Q value = 0.022
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
7Q GAIN MUTATED | 192 | 46 |
7Q GAIN WILD-TYPE | 354 | 43 |
P value = 8.05e-07 (Fisher's exact test), Q value = 9.2e-05
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
7Q GAIN MUTATED | 89 | 282 |
7Q GAIN WILD-TYPE | 203 | 308 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
7Q GAIN MUTATED | 24 | 174 | 173 |
7Q GAIN WILD-TYPE | 42 | 354 | 115 |
P value = 0.00638 (Wilcoxon-test), Q value = 0.031
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
7Q GAIN MUTATED | 38 | 1968.8 (15.1) |
7Q GAIN WILD-TYPE | 36 | 1978.9 (15.5) |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
8P GAIN MUTATED | 18 | 19 | 19 | 12 |
8P GAIN WILD-TYPE | 436 | 84 | 171 | 92 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
8P GAIN MUTATED | 18 | 20 | 30 | 1 |
8P GAIN WILD-TYPE | 462 | 107 | 228 | 14 |
P value = 0.0545 (Fisher's exact test), Q value = 0.17
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
8P GAIN MUTATED | 30 | 7 | 2 |
8P GAIN WILD-TYPE | 293 | 37 | 4 |
P value = 7e-05 (Fisher's exact test), Q value = 0.00061
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
8P GAIN MUTATED | 16 | 33 | 20 |
8P GAIN WILD-TYPE | 50 | 495 | 268 |
P value = 0.00853 (logrank test), Q value = 0.039
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
8Q GAIN MUTATED | 102 | 35 | 0.2 - 153.7 (27.6) |
8Q GAIN WILD-TYPE | 774 | 193 | 0.1 - 194.8 (36.7) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
8Q GAIN MUTATED | 27 | 23 | 29 | 22 |
8Q GAIN WILD-TYPE | 427 | 80 | 161 | 82 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
8Q GAIN MUTATED | 28 | 24 | 48 | 3 |
8Q GAIN WILD-TYPE | 452 | 103 | 210 | 12 |
P value = 0.00393 (Fisher's exact test), Q value = 0.021
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
8Q GAIN MUTATED | 42 | 12 | 3 |
8Q GAIN WILD-TYPE | 281 | 32 | 3 |
P value = 0.0124 (Fisher's exact test), Q value = 0.052
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
8Q GAIN MUTATED | 57 | 18 |
8Q GAIN WILD-TYPE | 489 | 71 |
P value = 0.00133 (Fisher's exact test), Q value = 0.0083
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
8Q GAIN MUTATED | 17 | 61 | 25 |
8Q GAIN WILD-TYPE | 49 | 467 | 263 |
P value = 0.00315 (Fisher's exact test), Q value = 0.017
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
9P GAIN MUTATED | 7 | 9 | 7 | 3 |
9P GAIN WILD-TYPE | 447 | 94 | 183 | 101 |
P value = 0.00163 (Fisher's exact test), Q value = 0.0097
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
9P GAIN MUTATED | 7 | 9 | 8 | 2 |
9P GAIN WILD-TYPE | 473 | 118 | 250 | 13 |
P value = 0.0581 (Fisher's exact test), Q value = 0.18
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
9P GAIN MUTATED | 22 | 0 |
9P GAIN WILD-TYPE | 524 | 89 |
P value = 0.0101 (Fisher's exact test), Q value = 0.044
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
9P GAIN MUTATED | 15 | 11 |
9P GAIN WILD-TYPE | 277 | 579 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
9P GAIN MUTATED | 9 | 14 | 3 |
9P GAIN WILD-TYPE | 57 | 514 | 285 |
P value = 0.00113 (Fisher's exact test), Q value = 0.0072
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
9Q GAIN MUTATED | 5 | 8 | 6 | 5 |
9Q GAIN WILD-TYPE | 449 | 95 | 184 | 99 |
P value = 0.00012 (Fisher's exact test), Q value = 0.001
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
9Q GAIN MUTATED | 5 | 8 | 8 | 3 |
9Q GAIN WILD-TYPE | 475 | 119 | 250 | 12 |
P value = 0.0449 (Fisher's exact test), Q value = 0.15
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
9Q GAIN MUTATED | 13 | 11 |
9Q GAIN WILD-TYPE | 279 | 579 |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
9Q GAIN MUTATED | 9 | 13 | 2 |
9Q GAIN WILD-TYPE | 57 | 515 | 286 |
P value = 0.00739 (Fisher's exact test), Q value = 0.035
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
10P GAIN MUTATED | 12 | 7 | 6 | 3 |
10P GAIN WILD-TYPE | 468 | 120 | 252 | 12 |
P value = 0.0141 (Fisher's exact test), Q value = 0.057
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
10P GAIN MUTATED | 7 | 4 | 1 |
10P GAIN WILD-TYPE | 316 | 40 | 5 |
P value = 0.0465 (Fisher's exact test), Q value = 0.15
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
10Q GAIN MUTATED | 11 | 5 | 4 | 2 |
10Q GAIN WILD-TYPE | 469 | 122 | 254 | 13 |
P value = 0.0238 (Fisher's exact test), Q value = 0.09
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
10Q GAIN MUTATED | 6 | 3 | 1 |
10Q GAIN WILD-TYPE | 317 | 41 | 5 |
P value = 0.00425 (Fisher's exact test), Q value = 0.022
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
11P GAIN MUTATED | 18 | 9 | 18 | 12 |
11P GAIN WILD-TYPE | 436 | 94 | 172 | 92 |
P value = 0.00131 (Fisher's exact test), Q value = 0.0082
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
11P GAIN MUTATED | 18 | 11 | 28 | 1 |
11P GAIN WILD-TYPE | 462 | 116 | 230 | 14 |
P value = 0.0371 (Fisher's exact test), Q value = 0.13
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
11P GAIN MUTATED | 32 | 11 |
11P GAIN WILD-TYPE | 514 | 78 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
11P GAIN MUTATED | 15 | 31 | 12 |
11P GAIN WILD-TYPE | 51 | 497 | 276 |
P value = 0.0422 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
11P GAIN MUTATED | 8 | 17.0 (15.3) |
11P GAIN WILD-TYPE | 98 | 31.9 (25.2) |
P value = 0.0524 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
11Q GAIN MUTATED | 55 | 57.0 (12.8) |
11Q GAIN WILD-TYPE | 821 | 60.4 (12.5) |
P value = 0.0346 (Fisher's exact test), Q value = 0.12
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
11Q GAIN MUTATED | 19 | 9 | 16 | 10 |
11Q GAIN WILD-TYPE | 435 | 94 | 174 | 94 |
P value = 0.00897 (Fisher's exact test), Q value = 0.04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
11Q GAIN MUTATED | 19 | 11 | 25 | 0 |
11Q GAIN WILD-TYPE | 461 | 116 | 233 | 15 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
11Q GAIN MUTATED | 16 | 29 | 10 |
11Q GAIN WILD-TYPE | 50 | 499 | 278 |
P value = 0.0422 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
11Q GAIN MUTATED | 8 | 17.0 (15.3) |
11Q GAIN WILD-TYPE | 98 | 31.9 (25.2) |
P value = 0.0498 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
11Q GAIN MUTATED | 6 | 1985.3 (11.3) |
11Q GAIN WILD-TYPE | 68 | 1972.7 (16.0) |
P value = 0.0583 (Fisher's exact test), Q value = 0.18
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
12P GAIN MUTATED | 118 | 27 | 54 | 41 |
12P GAIN WILD-TYPE | 336 | 76 | 136 | 63 |
P value = 0.00852 (Fisher's exact test), Q value = 0.039
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
12P GAIN MUTATED | 87 | 21 | 3 |
12P GAIN WILD-TYPE | 236 | 23 | 3 |
P value = 0.00873 (Fisher's exact test), Q value = 0.039
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
12P GAIN MUTATED | 129 | 33 |
12P GAIN WILD-TYPE | 417 | 56 |
P value = 0.00562 (Fisher's exact test), Q value = 0.028
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
12P GAIN MUTATED | 66 | 186 |
12P GAIN WILD-TYPE | 226 | 404 |
P value = 0.0571 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
12P GAIN MUTATED | 50 | 84.2 (26.4) |
12P GAIN WILD-TYPE | 93 | 89.6 (20.4) |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
12P GAIN MUTATED | 19 | 121 | 112 |
12P GAIN WILD-TYPE | 47 | 407 | 176 |
P value = 0.0792 (Fisher's exact test), Q value = 0.22
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
12P GAIN MUTATED | 7 | 190 |
12P GAIN WILD-TYPE | 35 | 432 |
P value = 0.0708 (logrank test), Q value = 0.21
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
12Q GAIN MUTATED | 252 | 71 | 0.1 - 194.8 (28.9) |
12Q GAIN WILD-TYPE | 624 | 157 | 0.1 - 149.2 (37.5) |
P value = 0.0337 (Fisher's exact test), Q value = 0.12
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
12Q GAIN MUTATED | 118 | 27 | 57 | 42 |
12Q GAIN WILD-TYPE | 336 | 76 | 133 | 62 |
P value = 0.0669 (Fisher's exact test), Q value = 0.2
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
12Q GAIN MUTATED | 126 | 34 | 87 | 7 |
12Q GAIN WILD-TYPE | 354 | 93 | 171 | 8 |
P value = 0.00279 (Fisher's exact test), Q value = 0.015
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
12Q GAIN MUTATED | 88 | 21 | 4 |
12Q GAIN WILD-TYPE | 235 | 23 | 2 |
P value = 0.013 (Fisher's exact test), Q value = 0.054
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
12Q GAIN MUTATED | 132 | 33 |
12Q GAIN WILD-TYPE | 414 | 56 |
P value = 0.00574 (Fisher's exact test), Q value = 0.028
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
12Q GAIN MUTATED | 67 | 189 |
12Q GAIN WILD-TYPE | 225 | 401 |
P value = 0.0571 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
12Q GAIN MUTATED | 50 | 84.2 (26.4) |
12Q GAIN WILD-TYPE | 93 | 89.6 (20.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
12Q GAIN MUTATED | 21 | 123 | 112 |
12Q GAIN WILD-TYPE | 45 | 405 | 176 |
P value = 0.0557 (Fisher's exact test), Q value = 0.17
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
12Q GAIN MUTATED | 7 | 193 |
12Q GAIN WILD-TYPE | 35 | 429 |
P value = 0.0909 (logrank test), Q value = 0.25
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
13Q GAIN MUTATED | 52 | 8 | 0.4 - 133.7 (39.8) |
13Q GAIN WILD-TYPE | 824 | 220 | 0.1 - 194.8 (35.5) |
P value = 0.0148 (Fisher's exact test), Q value = 0.06
nPatients | NO | YES |
---|---|---|
ALL | 408 | 3 |
13Q GAIN MUTATED | 28 | 2 |
13Q GAIN WILD-TYPE | 380 | 1 |
P value = 0.00483 (Fisher's exact test), Q value = 0.024
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
13Q GAIN MUTATED | 2 | 22 | 28 |
13Q GAIN WILD-TYPE | 64 | 506 | 260 |
P value = 0.0426 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
14Q GAIN MUTATED | 38 | 56.4 (12.4) |
14Q GAIN WILD-TYPE | 838 | 60.3 (12.5) |
P value = 0.00141 (Fisher's exact test), Q value = 0.0087
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
14Q GAIN MUTATED | 12 | 12 | 8 | 7 |
14Q GAIN WILD-TYPE | 442 | 91 | 182 | 97 |
P value = 4e-04 (Fisher's exact test), Q value = 0.0029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
14Q GAIN MUTATED | 12 | 12 | 12 | 3 |
14Q GAIN WILD-TYPE | 468 | 115 | 246 | 12 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
14Q GAIN MUTATED | 20 | 16 | 3 |
14Q GAIN WILD-TYPE | 46 | 512 | 285 |
P value = 0.084 (Wilcoxon-test), Q value = 0.23
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
14Q GAIN MUTATED | 3 | 1989.0 (7.0) |
14Q GAIN WILD-TYPE | 71 | 1973.1 (16.0) |
P value = 0.00095 (Fisher's exact test), Q value = 0.0063
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
15Q GAIN MUTATED | 17 | 15 | 11 | 9 |
15Q GAIN WILD-TYPE | 437 | 88 | 179 | 95 |
P value = 0.00311 (Fisher's exact test), Q value = 0.017
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
15Q GAIN MUTATED | 17 | 15 | 19 | 1 |
15Q GAIN WILD-TYPE | 463 | 112 | 239 | 14 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
15Q GAIN MUTATED | 21 | 26 | 5 |
15Q GAIN WILD-TYPE | 45 | 502 | 283 |
P value = 0.0588 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
15Q GAIN MUTATED | 4 | 1987.5 (12.7) |
15Q GAIN WILD-TYPE | 70 | 1972.9 (15.9) |
P value = 0.0201 (logrank test), Q value = 0.078
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
16P GAIN MUTATED | 277 | 56 | 0.1 - 194.8 (30.7) |
16P GAIN WILD-TYPE | 599 | 172 | 0.1 - 149.2 (36.9) |
P value = 0.0129 (Wilcoxon-test), Q value = 0.053
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
16P GAIN MUTATED | 279 | 61.6 (12.2) |
16P GAIN WILD-TYPE | 597 | 59.5 (12.6) |
P value = 0.00212 (Fisher's exact test), Q value = 0.012
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
16P GAIN MUTATED | 73 | 208 |
16P GAIN WILD-TYPE | 219 | 382 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
16P GAIN MUTATED | 21 | 107 | 153 |
16P GAIN WILD-TYPE | 45 | 421 | 135 |
P value = 0.0379 (Fisher's exact test), Q value = 0.13
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
16P GAIN MUTATED | 2 | 5 | 29 | 238 |
16P GAIN WILD-TYPE | 0 | 11 | 92 | 481 |
P value = 0.00215 (logrank test), Q value = 0.012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
16Q GAIN MUTATED | 264 | 49 | 0.1 - 194.8 (31.4) |
16Q GAIN WILD-TYPE | 612 | 179 | 0.1 - 149.2 (36.5) |
P value = 0.0317 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
16Q GAIN MUTATED | 266 | 61.5 (12.3) |
16Q GAIN WILD-TYPE | 610 | 59.6 (12.6) |
P value = 0.0102 (Fisher's exact test), Q value = 0.044
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
16Q GAIN MUTATED | 72 | 196 |
16Q GAIN WILD-TYPE | 220 | 394 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
16Q GAIN MUTATED | 21 | 99 | 148 |
16Q GAIN WILD-TYPE | 45 | 429 | 140 |
P value = 0.0122 (logrank test), Q value = 0.051
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
17P GAIN MUTATED | 193 | 27 | 0.1 - 194.8 (25.6) |
17P GAIN WILD-TYPE | 683 | 201 | 0.1 - 153.7 (38.7) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
17P GAIN MUTATED | 131 | 19 | 23 | 6 |
17P GAIN WILD-TYPE | 323 | 84 | 167 | 98 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
17P GAIN MUTATED | 141 | 26 | 26 | 2 |
17P GAIN WILD-TYPE | 339 | 101 | 232 | 13 |
P value = 0.0184 (Fisher's exact test), Q value = 0.072
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
17P GAIN MUTATED | 32 | 11 | 0 |
17P GAIN WILD-TYPE | 291 | 33 | 6 |
P value = 0.01 (Fisher's exact test), Q value = 0.044
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
17P GAIN MUTATED | 68 | 3 |
17P GAIN WILD-TYPE | 478 | 86 |
P value = 0.000289 (Fisher's exact test), Q value = 0.0022
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
17P GAIN MUTATED | 44 | 152 |
17P GAIN WILD-TYPE | 248 | 438 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
17P GAIN MUTATED | 0 | 25 | 171 |
17P GAIN WILD-TYPE | 66 | 503 | 117 |
P value = 0.00884 (Fisher's exact test), Q value = 0.039
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
17P GAIN MUTATED | 2 | 6 | 33 | 147 |
17P GAIN WILD-TYPE | 0 | 10 | 88 | 572 |
P value = 0.0104 (Fisher's exact test), Q value = 0.045
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
17P GAIN MUTATED | 4 | 168 |
17P GAIN WILD-TYPE | 38 | 454 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
17Q GAIN MUTATED | 139 | 20 | 33 | 11 |
17Q GAIN WILD-TYPE | 315 | 83 | 157 | 93 |
P value = 7e-05 (Fisher's exact test), Q value = 0.00061
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
17Q GAIN MUTATED | 149 | 28 | 41 | 3 |
17Q GAIN WILD-TYPE | 331 | 99 | 217 | 12 |
P value = 0.00356 (Fisher's exact test), Q value = 0.019
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
17Q GAIN MUTATED | 42 | 12 | 3 |
17Q GAIN WILD-TYPE | 281 | 32 | 3 |
P value = 0.0451 (Fisher's exact test), Q value = 0.15
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
17Q GAIN MUTATED | 79 | 6 |
17Q GAIN WILD-TYPE | 467 | 83 |
P value = 0.0107 (Fisher's exact test), Q value = 0.046
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
17Q GAIN MUTATED | 58 | 164 |
17Q GAIN WILD-TYPE | 234 | 426 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
17Q GAIN MUTATED | 0 | 32 | 190 |
17Q GAIN WILD-TYPE | 66 | 496 | 98 |
P value = 0.0118 (Fisher's exact test), Q value = 0.05
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
17Q GAIN MUTATED | 2 | 6 | 38 | 167 |
17Q GAIN WILD-TYPE | 0 | 10 | 83 | 552 |
P value = 0.0341 (Fisher's exact test), Q value = 0.12
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
17Q GAIN MUTATED | 6 | 185 |
17Q GAIN WILD-TYPE | 36 | 437 |
P value = 0.00923 (logrank test), Q value = 0.04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
18P GAIN MUTATED | 54 | 7 | 0.5 - 153.7 (48.9) |
18P GAIN WILD-TYPE | 822 | 221 | 0.1 - 194.8 (34.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
18P GAIN MUTATED | 16 | 25 | 13 |
18P GAIN WILD-TYPE | 50 | 503 | 275 |
P value = 0.0758 (Fisher's exact test), Q value = 0.22
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
18P GAIN MUTATED | 0 | 0 | 2 | 50 |
18P GAIN WILD-TYPE | 2 | 16 | 119 | 669 |
P value = 0.00765 (logrank test), Q value = 0.035
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
18Q GAIN MUTATED | 50 | 6 | 0.5 - 153.7 (48.9) |
18Q GAIN WILD-TYPE | 826 | 222 | 0.1 - 194.8 (34.6) |
P value = 0.0275 (Wilcoxon-test), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
18Q GAIN MUTATED | 9 | 97.8 (6.7) |
18Q GAIN WILD-TYPE | 134 | 87.0 (23.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
18Q GAIN MUTATED | 16 | 25 | 9 |
18Q GAIN WILD-TYPE | 50 | 503 | 279 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
19P GAIN MUTATED | 21 | 16 | 17 | 20 |
19P GAIN WILD-TYPE | 433 | 87 | 173 | 84 |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
19P GAIN MUTATED | 22 | 16 | 33 | 3 |
19P GAIN WILD-TYPE | 458 | 111 | 225 | 12 |
P value = 0.0107 (Fisher's exact test), Q value = 0.046
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
19P GAIN MUTATED | 46 | 16 |
19P GAIN WILD-TYPE | 500 | 73 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
19P GAIN MUTATED | 20 | 50 | 4 |
19P GAIN WILD-TYPE | 46 | 478 | 284 |
P value = 0.00161 (Fisher's exact test), Q value = 0.0096
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
19P GAIN MUTATED | 0 | 1 | 1 | 72 |
19P GAIN WILD-TYPE | 2 | 15 | 120 | 647 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
19Q GAIN MUTATED | 22 | 16 | 20 | 20 |
19Q GAIN WILD-TYPE | 432 | 87 | 170 | 84 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00037
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
19Q GAIN MUTATED | 23 | 18 | 35 | 2 |
19Q GAIN WILD-TYPE | 457 | 109 | 223 | 13 |
P value = 0.00274 (Fisher's exact test), Q value = 0.015
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
19Q GAIN MUTATED | 49 | 18 |
19Q GAIN WILD-TYPE | 497 | 71 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
19Q GAIN MUTATED | 18 | 56 | 4 |
19Q GAIN WILD-TYPE | 48 | 472 | 284 |
P value = 0.00064 (Fisher's exact test), Q value = 0.0044
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
19Q GAIN MUTATED | 0 | 1 | 1 | 76 |
19Q GAIN WILD-TYPE | 2 | 15 | 120 | 643 |
P value = 0.00872 (Fisher's exact test), Q value = 0.039
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
20P GAIN MUTATED | 99 | 31 | 54 | 38 |
20P GAIN WILD-TYPE | 355 | 72 | 136 | 66 |
P value = 0.00374 (Fisher's exact test), Q value = 0.02
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
20P GAIN MUTATED | 107 | 37 | 81 | 8 |
20P GAIN WILD-TYPE | 373 | 90 | 177 | 7 |
P value = 0.0618 (Fisher's exact test), Q value = 0.18
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
20P GAIN MUTATED | 76 | 16 | 3 |
20P GAIN WILD-TYPE | 247 | 28 | 3 |
P value = 0.0461 (Fisher's exact test), Q value = 0.15
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
20P GAIN MUTATED | 127 | 30 |
20P GAIN WILD-TYPE | 419 | 59 |
P value = 0.00114 (Fisher's exact test), Q value = 0.0073
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
20P GAIN MUTATED | 57 | 176 |
20P GAIN WILD-TYPE | 235 | 414 |
P value = 0.00022 (Fisher's exact test), Q value = 0.0018
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
20P GAIN MUTATED | 21 | 113 | 99 |
20P GAIN WILD-TYPE | 45 | 415 | 189 |
P value = 0.00751 (Fisher's exact test), Q value = 0.035
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
20Q GAIN MUTATED | 100 | 31 | 57 | 38 |
20Q GAIN WILD-TYPE | 354 | 72 | 133 | 66 |
P value = 0.00729 (Fisher's exact test), Q value = 0.034
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
20Q GAIN MUTATED | 109 | 37 | 84 | 7 |
20Q GAIN WILD-TYPE | 371 | 90 | 174 | 8 |
P value = 0.0202 (Fisher's exact test), Q value = 0.078
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
20Q GAIN MUTATED | 77 | 18 | 3 |
20Q GAIN WILD-TYPE | 246 | 26 | 3 |
P value = 0.0651 (Fisher's exact test), Q value = 0.19
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
20Q GAIN MUTATED | 131 | 30 |
20Q GAIN WILD-TYPE | 415 | 59 |
P value = 0.00282 (Fisher's exact test), Q value = 0.016
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
20Q GAIN MUTATED | 60 | 177 |
20Q GAIN WILD-TYPE | 232 | 413 |
P value = 0.00014 (Fisher's exact test), Q value = 0.0012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
20Q GAIN MUTATED | 21 | 115 | 101 |
20Q GAIN WILD-TYPE | 45 | 413 | 187 |
P value = 0.0417 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
21Q GAIN MUTATED | 14 | 95.7 (9.4) |
21Q GAIN WILD-TYPE | 129 | 86.8 (23.6) |
P value = 0.0613 (Fisher's exact test), Q value = 0.18
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
21Q GAIN MUTATED | 1 | 1 | 5 | 64 |
21Q GAIN WILD-TYPE | 1 | 15 | 116 | 655 |
P value = 0.0138 (Fisher's exact test), Q value = 0.056
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
22Q GAIN MUTATED | 23 | 13 | 15 | 12 |
22Q GAIN WILD-TYPE | 431 | 90 | 175 | 92 |
P value = 0.0017 (Fisher's exact test), Q value = 0.01
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
22Q GAIN MUTATED | 23 | 14 | 23 | 4 |
22Q GAIN WILD-TYPE | 457 | 113 | 235 | 11 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
22Q GAIN MUTATED | 19 | 40 | 5 |
22Q GAIN WILD-TYPE | 47 | 488 | 283 |
P value = 0.0343 (Fisher's exact test), Q value = 0.12
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
XP GAIN MUTATED | 74 | 14 | 15 | 16 |
XP GAIN WILD-TYPE | 380 | 89 | 175 | 88 |
P value = 0.0614 (Fisher's exact test), Q value = 0.18
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
XP GAIN MUTATED | 81 | 19 | 26 | 3 |
XP GAIN WILD-TYPE | 399 | 108 | 232 | 12 |
P value = 0.00608 (Fisher's exact test), Q value = 0.03
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
XP GAIN MUTATED | 29 | 100 |
XP GAIN WILD-TYPE | 263 | 490 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
XP GAIN MUTATED | 8 | 33 | 88 |
XP GAIN WILD-TYPE | 58 | 495 | 200 |
P value = 0.057 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
XP GAIN MUTATED | 17 | 1967.9 (13.8) |
XP GAIN WILD-TYPE | 57 | 1975.5 (16.3) |
P value = 0.033 (Fisher's exact test), Q value = 0.12
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
XP GAIN MUTATED | 2 | 3 | 19 | 99 |
XP GAIN WILD-TYPE | 0 | 13 | 102 | 620 |
P value = 0.0762 (logrank test), Q value = 0.22
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
XQ GAIN MUTATED | 128 | 23 | 0.1 - 194.8 (29.8) |
XQ GAIN WILD-TYPE | 748 | 205 | 0.1 - 153.7 (36.5) |
P value = 0.0643 (Fisher's exact test), Q value = 0.19
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
XQ GAIN MUTATED | 74 | 14 | 16 | 15 |
XQ GAIN WILD-TYPE | 380 | 89 | 174 | 89 |
P value = 0.00859 (Fisher's exact test), Q value = 0.039
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
XQ GAIN MUTATED | 30 | 100 |
XQ GAIN WILD-TYPE | 262 | 490 |
P value = 0.074 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
XQ GAIN MUTATED | 30 | 91.7 (19.3) |
XQ GAIN WILD-TYPE | 113 | 86.6 (23.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
XQ GAIN MUTATED | 8 | 32 | 90 |
XQ GAIN WILD-TYPE | 58 | 496 | 198 |
P value = 0.0226 (Fisher's exact test), Q value = 0.086
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
XQ GAIN MUTATED | 2 | 2 | 22 | 98 |
XQ GAIN WILD-TYPE | 0 | 14 | 99 | 621 |
P value = 0.0108 (Wilcoxon-test), Q value = 0.046
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
1P LOSS MUTATED | 145 | 57.4 (14.0) |
1P LOSS WILD-TYPE | 731 | 60.7 (12.1) |
P value = 6e-05 (Fisher's exact test), Q value = 0.00053
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
1P LOSS MUTATED | 56 | 34 | 32 | 17 |
1P LOSS WILD-TYPE | 398 | 69 | 158 | 87 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00045
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
1P LOSS MUTATED | 60 | 38 | 42 | 5 |
1P LOSS WILD-TYPE | 420 | 89 | 216 | 10 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
1P LOSS MUTATED | 53 | 60 | 32 |
1P LOSS WILD-TYPE | 13 | 468 | 256 |
P value = 0.0236 (logrank test), Q value = 0.09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
1Q LOSS MUTATED | 109 | 24 | 0.1 - 153.7 (49.6) |
1Q LOSS WILD-TYPE | 767 | 204 | 0.1 - 194.8 (33.5) |
P value = 0.00104 (Wilcoxon-test), Q value = 0.0068
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
1Q LOSS MUTATED | 110 | 56.0 (14.0) |
1Q LOSS WILD-TYPE | 766 | 60.7 (12.2) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
1Q LOSS MUTATED | 44 | 30 | 21 | 11 |
1Q LOSS WILD-TYPE | 410 | 73 | 169 | 93 |
P value = 0.00015 (Fisher's exact test), Q value = 0.0012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
1Q LOSS MUTATED | 47 | 31 | 28 | 4 |
1Q LOSS WILD-TYPE | 433 | 96 | 230 | 11 |
P value = 0.0522 (Fisher's exact test), Q value = 0.17
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
1Q LOSS MUTATED | 72 | 5 |
1Q LOSS WILD-TYPE | 474 | 84 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
1Q LOSS MUTATED | 52 | 38 | 20 |
1Q LOSS WILD-TYPE | 14 | 490 | 268 |
P value = 0.00429 (logrank test), Q value = 0.022
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
2P LOSS MUTATED | 64 | 12 | 2.5 - 153.7 (65.9) |
2P LOSS WILD-TYPE | 812 | 216 | 0.1 - 194.8 (33.3) |
P value = 4.4e-05 (Wilcoxon-test), Q value = 4e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
2P LOSS MUTATED | 64 | 53.4 (14.2) |
2P LOSS WILD-TYPE | 812 | 60.7 (12.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
2P LOSS MUTATED | 20 | 24 | 14 | 5 |
2P LOSS WILD-TYPE | 434 | 79 | 176 | 99 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
2P LOSS MUTATED | 21 | 25 | 18 | 1 |
2P LOSS WILD-TYPE | 459 | 102 | 240 | 14 |
P value = 0.0701 (Fisher's exact test), Q value = 0.2
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
2P LOSS MUTATED | 42 | 2 |
2P LOSS WILD-TYPE | 504 | 87 |
P value = 0.0487 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
2P LOSS MUTATED | 9 | 97.8 (4.4) |
2P LOSS WILD-TYPE | 134 | 87.0 (23.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
2P LOSS MUTATED | 46 | 14 | 5 |
2P LOSS WILD-TYPE | 20 | 514 | 283 |
P value = 0.00297 (logrank test), Q value = 0.016
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
2Q LOSS MUTATED | 62 | 11 | 2.5 - 153.7 (65.9) |
2Q LOSS WILD-TYPE | 814 | 217 | 0.1 - 194.8 (33.3) |
P value = 2.51e-05 (Wilcoxon-test), Q value = 0.00025
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
2Q LOSS MUTATED | 62 | 53.0 (14.3) |
2Q LOSS WILD-TYPE | 814 | 60.7 (12.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
2Q LOSS MUTATED | 19 | 24 | 14 | 5 |
2Q LOSS WILD-TYPE | 435 | 79 | 176 | 99 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
2Q LOSS MUTATED | 20 | 24 | 18 | 1 |
2Q LOSS WILD-TYPE | 460 | 103 | 240 | 14 |
P value = 0.0701 (Fisher's exact test), Q value = 0.2
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
2Q LOSS MUTATED | 41 | 2 |
2Q LOSS WILD-TYPE | 505 | 87 |
P value = 0.0487 (Wilcoxon-test), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
2Q LOSS MUTATED | 9 | 97.8 (4.4) |
2Q LOSS WILD-TYPE | 134 | 87.0 (23.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
2Q LOSS MUTATED | 46 | 14 | 3 |
2Q LOSS WILD-TYPE | 20 | 514 | 285 |
P value = 0.00287 (logrank test), Q value = 0.016
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
3P LOSS MUTATED | 410 | 134 | 0.1 - 153.7 (39.7) |
3P LOSS WILD-TYPE | 466 | 94 | 0.1 - 194.8 (30.3) |
P value = 0.00055 (Fisher's exact test), Q value = 0.0038
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
3P LOSS MUTATED | 190 | 49 | 112 | 57 |
3P LOSS WILD-TYPE | 264 | 54 | 78 | 47 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
3P LOSS MUTATED | 195 | 61 | 151 | 4 |
3P LOSS WILD-TYPE | 285 | 66 | 107 | 11 |
P value = 0.0729 (Fisher's exact test), Q value = 0.21
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
3P LOSS MUTATED | 179 | 17 | 2 |
3P LOSS WILD-TYPE | 144 | 27 | 4 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
3P LOSS MUTATED | 8 | 381 | 22 |
3P LOSS WILD-TYPE | 58 | 147 | 266 |
P value = 0.0264 (Wilcoxon-test), Q value = 0.097
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
3P LOSS MUTATED | 16 | 1981.4 (18.7) |
3P LOSS WILD-TYPE | 58 | 1971.6 (14.6) |
P value = 0.00072 (Fisher's exact test), Q value = 0.0048
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
3P LOSS MUTATED | 0 | 6 | 39 | 359 |
3P LOSS WILD-TYPE | 2 | 10 | 82 | 360 |
P value = 0.0451 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
3Q LOSS MUTATED | 119 | 62.5 (13.2) |
3Q LOSS WILD-TYPE | 757 | 59.8 (12.4) |
P value = 0.0358 (Fisher's exact test), Q value = 0.12
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
3Q LOSS MUTATED | 29 | 90 |
3Q LOSS WILD-TYPE | 263 | 500 |
P value = 0.0158 (Fisher's exact test), Q value = 0.062
nPatients | NO | YES |
---|---|---|
ALL | 408 | 3 |
3Q LOSS MUTATED | 29 | 2 |
3Q LOSS WILD-TYPE | 379 | 1 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
3Q LOSS MUTATED | 7 | 105 | 7 |
3Q LOSS WILD-TYPE | 59 | 423 | 281 |
P value = 0.06 (Fisher's exact test), Q value = 0.18
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
3Q LOSS MUTATED | 0 | 1 | 8 | 107 |
3Q LOSS WILD-TYPE | 2 | 15 | 113 | 612 |
P value = 2.36e-11 (logrank test), Q value = 9e-09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
4P LOSS MUTATED | 98 | 51 | 0.5 - 133.7 (31.5) |
4P LOSS WILD-TYPE | 778 | 177 | 0.1 - 194.8 (36.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
4P LOSS MUTATED | 25 | 7 | 40 | 23 |
4P LOSS WILD-TYPE | 429 | 96 | 150 | 81 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
4P LOSS MUTATED | 27 | 11 | 55 | 5 |
4P LOSS WILD-TYPE | 453 | 116 | 203 | 10 |
P value = 0.00158 (Fisher's exact test), Q value = 0.0095
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
4P LOSS MUTATED | 36 | 14 | 1 |
4P LOSS WILD-TYPE | 287 | 30 | 5 |
P value = 0.0145 (Fisher's exact test), Q value = 0.059
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
4P LOSS MUTATED | 61 | 19 |
4P LOSS WILD-TYPE | 485 | 70 |
P value = 0.0538 (Fisher's exact test), Q value = 0.17
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
4P LOSS MUTATED | 41 | 57 |
4P LOSS WILD-TYPE | 251 | 533 |
P value = 0.00192 (Fisher's exact test), Q value = 0.011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
4P LOSS MUTATED | 1 | 72 | 25 |
4P LOSS WILD-TYPE | 65 | 456 | 263 |
P value = 6.76e-13 (logrank test), Q value = 7.8e-10
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
4Q LOSS MUTATED | 92 | 49 | 1.0 - 133.7 (22.8) |
4Q LOSS WILD-TYPE | 784 | 179 | 0.1 - 194.8 (36.7) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
4Q LOSS MUTATED | 20 | 7 | 37 | 25 |
4Q LOSS WILD-TYPE | 434 | 96 | 153 | 79 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
4Q LOSS MUTATED | 22 | 12 | 52 | 6 |
4Q LOSS WILD-TYPE | 458 | 115 | 206 | 9 |
P value = 0.00116 (Fisher's exact test), Q value = 0.0074
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
4Q LOSS MUTATED | 31 | 13 | 1 |
4Q LOSS WILD-TYPE | 292 | 31 | 5 |
P value = 0.000606 (Fisher's exact test), Q value = 0.0042
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
4Q LOSS MUTATED | 54 | 21 |
4Q LOSS WILD-TYPE | 492 | 68 |
P value = 0.00855 (Fisher's exact test), Q value = 0.039
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
4Q LOSS MUTATED | 1 | 65 | 26 |
4Q LOSS WILD-TYPE | 65 | 463 | 262 |
P value = 0.0571 (logrank test), Q value = 0.18
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
5P LOSS MUTATED | 23 | 11 | 2.8 - 153.7 (30.5) |
5P LOSS WILD-TYPE | 853 | 217 | 0.1 - 194.8 (35.9) |
P value = 0.0017 (Wilcoxon-test), Q value = 0.01
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
5P LOSS MUTATED | 24 | 51.0 (14.1) |
5P LOSS WILD-TYPE | 852 | 60.4 (12.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
5P LOSS MUTATED | 2 | 9 | 5 | 7 |
5P LOSS WILD-TYPE | 452 | 94 | 185 | 97 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
5P LOSS MUTATED | 2 | 10 | 10 | 2 |
5P LOSS WILD-TYPE | 478 | 117 | 248 | 13 |
P value = 0.0176 (Fisher's exact test), Q value = 0.069
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
5P LOSS MUTATED | 13 | 3 | 2 |
5P LOSS WILD-TYPE | 310 | 41 | 4 |
P value = 0.0816 (Fisher's exact test), Q value = 0.23
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
5P LOSS MUTATED | 12 | 12 |
5P LOSS WILD-TYPE | 280 | 578 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
5P LOSS MUTATED | 10 | 8 | 6 |
5P LOSS WILD-TYPE | 56 | 520 | 282 |
P value = 0.0793 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
5P LOSS MUTATED | 5 | 15.8 (15.7) |
5P LOSS WILD-TYPE | 101 | 31.5 (25.0) |
P value = 0.086 (Fisher's exact test), Q value = 0.24
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
5P LOSS MUTATED | 3 | 14 |
5P LOSS WILD-TYPE | 39 | 608 |
P value = 0.000448 (Wilcoxon-test), Q value = 0.0033
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
5Q LOSS MUTATED | 23 | 49.4 (15.3) |
5Q LOSS WILD-TYPE | 853 | 60.4 (12.3) |
P value = 8e-05 (Fisher's exact test), Q value = 0.00069
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
5Q LOSS MUTATED | 3 | 9 | 6 | 4 |
5Q LOSS WILD-TYPE | 451 | 94 | 184 | 100 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00037
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
5Q LOSS MUTATED | 3 | 9 | 9 | 2 |
5Q LOSS WILD-TYPE | 477 | 118 | 249 | 13 |
P value = 0.0488 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
5Q LOSS MUTATED | 11 | 4 | 1 |
5Q LOSS WILD-TYPE | 312 | 40 | 5 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
5Q LOSS MUTATED | 10 | 6 | 7 |
5Q LOSS WILD-TYPE | 56 | 522 | 281 |
P value = 0.037 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 30.8 (24.9) |
5Q LOSS MUTATED | 4 | 12.2 (15.6) |
5Q LOSS WILD-TYPE | 102 | 31.5 (24.9) |
P value = 0.074 (Fisher's exact test), Q value = 0.21
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
5Q LOSS MUTATED | 3 | 13 |
5Q LOSS WILD-TYPE | 39 | 609 |
P value = 0.0574 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
6P LOSS MUTATED | 169 | 58.0 (14.7) |
6P LOSS WILD-TYPE | 707 | 60.7 (11.9) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
6P LOSS MUTATED | 58 | 36 | 46 | 28 |
6P LOSS WILD-TYPE | 396 | 67 | 144 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
6P LOSS MUTATED | 61 | 39 | 66 | 5 |
6P LOSS WILD-TYPE | 419 | 88 | 192 | 10 |
P value = 0.0542 (Fisher's exact test), Q value = 0.17
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
6P LOSS MUTATED | 73 | 11 | 4 |
6P LOSS WILD-TYPE | 250 | 33 | 2 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
6P LOSS MUTATED | 50 | 100 | 21 |
6P LOSS WILD-TYPE | 16 | 428 | 267 |
P value = 0.00039 (Fisher's exact test), Q value = 0.0029
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
6P LOSS MUTATED | 0 | 4 | 8 | 152 |
6P LOSS WILD-TYPE | 2 | 12 | 113 | 567 |
P value = 0.0567 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
6Q LOSS MUTATED | 204 | 58.2 (14.1) |
6Q LOSS WILD-TYPE | 672 | 60.7 (12.0) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00029
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
6Q LOSS MUTATED | 81 | 40 | 50 | 32 |
6Q LOSS WILD-TYPE | 373 | 63 | 140 | 72 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
6Q LOSS MUTATED | 83 | 43 | 73 | 7 |
6Q LOSS WILD-TYPE | 397 | 84 | 185 | 8 |
P value = 0.0442 (Fisher's exact test), Q value = 0.15
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
6Q LOSS MUTATED | 83 | 15 | 4 |
6Q LOSS WILD-TYPE | 240 | 29 | 2 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
6Q LOSS MUTATED | 51 | 128 | 27 |
6Q LOSS WILD-TYPE | 15 | 400 | 261 |
P value = 7e-04 (Fisher's exact test), Q value = 0.0047
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
6Q LOSS MUTATED | 0 | 6 | 13 | 179 |
6Q LOSS WILD-TYPE | 2 | 10 | 108 | 540 |
P value = 0.0855 (logrank test), Q value = 0.24
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
7P LOSS MUTATED | 4 | 2 | 1.4 - 84.9 (9.5) |
7P LOSS WILD-TYPE | 872 | 226 | 0.1 - 194.8 (35.9) |
P value = 0.0477 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
7P LOSS MUTATED | 1 | 2 | 0 |
7P LOSS WILD-TYPE | 322 | 42 | 6 |
P value = 0.0855 (logrank test), Q value = 0.24
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
7Q LOSS MUTATED | 4 | 2 | 1.4 - 84.9 (9.5) |
7Q LOSS WILD-TYPE | 872 | 226 | 0.1 - 194.8 (35.9) |
P value = 0.0481 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
7Q LOSS MUTATED | 1 | 2 | 0 |
7Q LOSS WILD-TYPE | 322 | 42 | 6 |
P value = 0.0148 (logrank test), Q value = 0.06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
8P LOSS MUTATED | 161 | 58 | 0.1 - 137.1 (40.0) |
8P LOSS WILD-TYPE | 715 | 170 | 0.1 - 194.8 (33.8) |
P value = 0.0324 (Fisher's exact test), Q value = 0.12
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
8P LOSS MUTATED | 69 | 21 | 38 | 28 |
8P LOSS WILD-TYPE | 385 | 82 | 152 | 76 |
P value = 0.0371 (Fisher's exact test), Q value = 0.13
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
8P LOSS MUTATED | 73 | 24 | 60 | 4 |
8P LOSS WILD-TYPE | 407 | 103 | 198 | 11 |
P value = 0.0402 (Fisher's exact test), Q value = 0.14
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
8P LOSS MUTATED | 116 | 28 |
8P LOSS WILD-TYPE | 430 | 61 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
8P LOSS MUTATED | 10 | 135 | 16 |
8P LOSS WILD-TYPE | 56 | 393 | 272 |
P value = 0.0321 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
8P LOSS MUTATED | 0 | 4 | 12 | 143 |
8P LOSS WILD-TYPE | 2 | 12 | 109 | 576 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
8Q LOSS MUTATED | 9 | 65 | 9 |
8Q LOSS WILD-TYPE | 57 | 463 | 279 |
P value = 3.48e-12 (logrank test), Q value = 2e-09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
9P LOSS MUTATED | 190 | 89 | 0.5 - 153.7 (36.5) |
9P LOSS WILD-TYPE | 686 | 139 | 0.1 - 194.8 (35.5) |
P value = 0.078 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
9P LOSS MUTATED | 190 | 61.5 (12.0) |
9P LOSS WILD-TYPE | 686 | 59.8 (12.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
9P LOSS MUTATED | 64 | 15 | 64 | 44 |
9P LOSS WILD-TYPE | 390 | 88 | 126 | 60 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
9P LOSS MUTATED | 69 | 22 | 94 | 7 |
9P LOSS WILD-TYPE | 411 | 105 | 164 | 8 |
P value = 0.00318 (Fisher's exact test), Q value = 0.017
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
9P LOSS MUTATED | 71 | 19 | 3 |
9P LOSS WILD-TYPE | 252 | 25 | 3 |
P value = 0.000125 (Fisher's exact test), Q value = 0.0011
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
9P LOSS MUTATED | 124 | 38 |
9P LOSS WILD-TYPE | 422 | 51 |
P value = 0.00183 (Wilcoxon-test), Q value = 0.011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
9P LOSS MUTATED | 28 | 76.8 (31.7) |
9P LOSS WILD-TYPE | 115 | 90.3 (19.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
9P LOSS MUTATED | 10 | 149 | 33 |
9P LOSS WILD-TYPE | 56 | 379 | 255 |
P value = 0.014 (Fisher's exact test), Q value = 0.057
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
9P LOSS MUTATED | 0 | 3 | 14 | 170 |
9P LOSS WILD-TYPE | 2 | 13 | 107 | 549 |
P value = 5.03e-10 (logrank test), Q value = 1.4e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
9Q LOSS MUTATED | 193 | 86 | 0.5 - 153.7 (36.4) |
9Q LOSS WILD-TYPE | 683 | 142 | 0.1 - 194.8 (35.9) |
P value = 0.0619 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
9Q LOSS MUTATED | 193 | 61.5 (12.2) |
9Q LOSS WILD-TYPE | 683 | 59.8 (12.6) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
9Q LOSS MUTATED | 63 | 19 | 67 | 42 |
9Q LOSS WILD-TYPE | 391 | 84 | 123 | 62 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
9Q LOSS MUTATED | 67 | 23 | 99 | 6 |
9Q LOSS WILD-TYPE | 413 | 104 | 159 | 9 |
P value = 0.0113 (Fisher's exact test), Q value = 0.048
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
9Q LOSS MUTATED | 74 | 18 | 3 |
9Q LOSS WILD-TYPE | 249 | 26 | 3 |
P value = 0.00159 (Fisher's exact test), Q value = 0.0095
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
9Q LOSS MUTATED | 129 | 36 |
9Q LOSS WILD-TYPE | 417 | 53 |
P value = 0.00118 (Wilcoxon-test), Q value = 0.0074
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
9Q LOSS MUTATED | 25 | 74.8 (33.1) |
9Q LOSS WILD-TYPE | 118 | 90.4 (19.0) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
9Q LOSS MUTATED | 11 | 150 | 34 |
9Q LOSS WILD-TYPE | 55 | 378 | 254 |
P value = 0.0115 (Fisher's exact test), Q value = 0.048
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
9Q LOSS MUTATED | 0 | 4 | 14 | 172 |
9Q LOSS WILD-TYPE | 2 | 12 | 107 | 547 |
P value = 0.0742 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
10P LOSS MUTATED | 132 | 57.9 (14.6) |
10P LOSS WILD-TYPE | 744 | 60.6 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
10P LOSS MUTATED | 42 | 27 | 43 | 19 |
10P LOSS WILD-TYPE | 412 | 76 | 147 | 85 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
10P LOSS MUTATED | 44 | 29 | 55 | 5 |
10P LOSS WILD-TYPE | 436 | 98 | 203 | 10 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
10P LOSS MUTATED | 48 | 68 | 17 |
10P LOSS WILD-TYPE | 18 | 460 | 271 |
P value = 0.0296 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
10Q LOSS MUTATED | 155 | 57.9 (14.1) |
10Q LOSS WILD-TYPE | 721 | 60.6 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
10Q LOSS MUTATED | 51 | 32 | 49 | 24 |
10Q LOSS WILD-TYPE | 403 | 71 | 141 | 80 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
10Q LOSS MUTATED | 53 | 34 | 63 | 7 |
10Q LOSS WILD-TYPE | 427 | 93 | 195 | 8 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
10Q LOSS MUTATED | 49 | 89 | 19 |
10Q LOSS WILD-TYPE | 17 | 439 | 269 |
P value = 0.00759 (logrank test), Q value = 0.035
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
11P LOSS MUTATED | 42 | 16 | 1.0 - 102.8 (23.7) |
11P LOSS WILD-TYPE | 834 | 212 | 0.1 - 194.8 (36.5) |
P value = 0.0463 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
11P LOSS MUTATED | 41 | 63.8 (10.9) |
11P LOSS WILD-TYPE | 835 | 60.0 (12.6) |
P value = 0.00142 (Fisher's exact test), Q value = 0.0087
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
11P LOSS MUTATED | 11 | 10 | 10 | 9 |
11P LOSS WILD-TYPE | 443 | 93 | 180 | 95 |
P value = 0.00113 (Fisher's exact test), Q value = 0.0072
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
11P LOSS MUTATED | 11 | 10 | 20 | 1 |
11P LOSS WILD-TYPE | 469 | 117 | 238 | 14 |
P value = 0.00063 (Fisher's exact test), Q value = 0.0044
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
11P LOSS MUTATED | 13 | 7 | 2 |
11P LOSS WILD-TYPE | 310 | 37 | 4 |
P value = 0.0194 (Fisher's exact test), Q value = 0.075
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
11P LOSS MUTATED | 7 | 18 | 17 |
11P LOSS WILD-TYPE | 59 | 510 | 271 |
P value = 0.000746 (logrank test), Q value = 0.005
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
11Q LOSS MUTATED | 52 | 21 | 0.4 - 123.6 (20.6) |
11Q LOSS WILD-TYPE | 824 | 207 | 0.1 - 194.8 (36.8) |
P value = 0.0151 (Wilcoxon-test), Q value = 0.06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
11Q LOSS MUTATED | 51 | 63.9 (11.6) |
11Q LOSS WILD-TYPE | 825 | 59.9 (12.5) |
P value = 4e-05 (Fisher's exact test), Q value = 0.00037
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
11Q LOSS MUTATED | 12 | 9 | 18 | 12 |
11Q LOSS WILD-TYPE | 442 | 94 | 172 | 92 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00037
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
11Q LOSS MUTATED | 12 | 10 | 29 | 1 |
11Q LOSS WILD-TYPE | 468 | 117 | 229 | 14 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
11Q LOSS MUTATED | 18 | 10 | 3 |
11Q LOSS WILD-TYPE | 305 | 34 | 3 |
P value = 0.0432 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
11Q LOSS MUTATED | 13 | 80.0 (27.4) |
11Q LOSS WILD-TYPE | 130 | 88.5 (22.2) |
P value = 0.0317 (Fisher's exact test), Q value = 0.11
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
11Q LOSS MUTATED | 7 | 23 | 22 |
11Q LOSS WILD-TYPE | 59 | 505 | 266 |
P value = 0.0479 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
12P LOSS MUTATED | 1 | 2 | 0 |
12P LOSS WILD-TYPE | 322 | 42 | 6 |
P value = 0.0542 (Fisher's exact test), Q value = 0.17
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
12Q LOSS MUTATED | 1 | 0 | 2 | 1 |
12Q LOSS WILD-TYPE | 479 | 127 | 256 | 14 |
P value = 0.0341 (logrank test), Q value = 0.12
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
13Q LOSS MUTATED | 135 | 50 | 0.2 - 153.7 (38.6) |
13Q LOSS WILD-TYPE | 741 | 178 | 0.1 - 194.8 (35.2) |
P value = 0.00011 (Wilcoxon-test), Q value = 0.00094
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
13Q LOSS MUTATED | 137 | 55.5 (14.9) |
13Q LOSS WILD-TYPE | 739 | 61.0 (11.8) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
13Q LOSS MUTATED | 43 | 21 | 44 | 28 |
13Q LOSS WILD-TYPE | 411 | 82 | 146 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
13Q LOSS MUTATED | 45 | 23 | 60 | 9 |
13Q LOSS WILD-TYPE | 435 | 104 | 198 | 6 |
P value = 0.00757 (Fisher's exact test), Q value = 0.035
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
13Q LOSS MUTATED | 63 | 14 | 4 |
13Q LOSS WILD-TYPE | 260 | 30 | 2 |
P value = 0.0137 (Fisher's exact test), Q value = 0.056
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
13Q LOSS MUTATED | 58 | 79 |
13Q LOSS WILD-TYPE | 234 | 511 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
13Q LOSS MUTATED | 43 | 71 | 23 |
13Q LOSS WILD-TYPE | 23 | 457 | 265 |
P value = 1.07e-09 (logrank test), Q value = 2.5e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
14Q LOSS MUTATED | 264 | 106 | 0.1 - 133.7 (31.7) |
14Q LOSS WILD-TYPE | 612 | 122 | 0.1 - 194.8 (37.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
14Q LOSS MUTATED | 97 | 29 | 77 | 54 |
14Q LOSS WILD-TYPE | 357 | 74 | 113 | 50 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
14Q LOSS MUTATED | 105 | 39 | 117 | 4 |
14Q LOSS WILD-TYPE | 375 | 88 | 141 | 11 |
P value = 0.00607 (Fisher's exact test), Q value = 0.03
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
14Q LOSS MUTATED | 102 | 23 | 4 |
14Q LOSS WILD-TYPE | 221 | 21 | 2 |
P value = 4.11e-05 (Fisher's exact test), Q value = 0.00038
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
14Q LOSS MUTATED | 175 | 49 |
14Q LOSS WILD-TYPE | 371 | 40 |
P value = 0.000194 (Wilcoxon-test), Q value = 0.0016
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
14Q LOSS MUTATED | 34 | 71.5 (37.0) |
14Q LOSS WILD-TYPE | 109 | 92.8 (12.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
14Q LOSS MUTATED | 2 | 216 | 47 |
14Q LOSS WILD-TYPE | 64 | 312 | 241 |
P value = 0.00516 (Wilcoxon-test), Q value = 0.026
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
14Q LOSS MUTATED | 14 | 1984.8 (14.5) |
14Q LOSS WILD-TYPE | 60 | 1971.2 (15.3) |
P value = 0.0208 (Fisher's exact test), Q value = 0.08
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
14Q LOSS MUTATED | 0 | 3 | 24 | 231 |
14Q LOSS WILD-TYPE | 2 | 13 | 97 | 488 |
P value = 1.98e-05 (logrank test), Q value = 2e-04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
15Q LOSS MUTATED | 68 | 28 | 0.1 - 99.0 (24.3) |
15Q LOSS WILD-TYPE | 808 | 200 | 0.1 - 194.8 (37.0) |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
15Q LOSS MUTATED | 20 | 4 | 23 | 17 |
15Q LOSS WILD-TYPE | 434 | 99 | 167 | 87 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
15Q LOSS MUTATED | 23 | 5 | 36 | 4 |
15Q LOSS WILD-TYPE | 457 | 122 | 222 | 11 |
P value = 0.00243 (Fisher's exact test), Q value = 0.014
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
15Q LOSS MUTATED | 22 | 9 | 2 |
15Q LOSS WILD-TYPE | 301 | 35 | 4 |
P value = 0.0139 (Fisher's exact test), Q value = 0.057
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
15Q LOSS MUTATED | 34 | 13 |
15Q LOSS WILD-TYPE | 512 | 76 |
P value = 0.0746 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
15Q LOSS MUTATED | 13 | 81.5 (26.7) |
15Q LOSS WILD-TYPE | 130 | 88.3 (22.3) |
P value = 0.0668 (Fisher's exact test), Q value = 0.2
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
15Q LOSS MUTATED | 2 | 36 | 30 |
15Q LOSS WILD-TYPE | 64 | 492 | 258 |
P value = 6.56e-06 (logrank test), Q value = 0.00012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
16P LOSS MUTATED | 18 | 11 | 0.1 - 80.2 (28.3) |
16P LOSS WILD-TYPE | 858 | 217 | 0.1 - 194.8 (36.4) |
P value = 0.00896 (Fisher's exact test), Q value = 0.04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
16P LOSS MUTATED | 4 | 2 | 6 | 6 |
16P LOSS WILD-TYPE | 450 | 101 | 184 | 98 |
P value = 0.00029 (Fisher's exact test), Q value = 0.0022
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
16P LOSS MUTATED | 4 | 2 | 9 | 3 |
16P LOSS WILD-TYPE | 476 | 125 | 249 | 12 |
P value = 0.00097 (Fisher's exact test), Q value = 0.0064
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
16P LOSS MUTATED | 6 | 4 | 2 |
16P LOSS WILD-TYPE | 317 | 40 | 4 |
P value = 0.0686 (Fisher's exact test), Q value = 0.2
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
16P LOSS MUTATED | 4 | 10 | 4 |
16P LOSS WILD-TYPE | 62 | 518 | 284 |
P value = 2.23e-06 (logrank test), Q value = 0.00012
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
16Q LOSS MUTATED | 28 | 16 | 0.1 - 80.2 (30.8) |
16Q LOSS WILD-TYPE | 848 | 212 | 0.1 - 194.8 (36.2) |
P value = 0.00488 (Fisher's exact test), Q value = 0.024
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
16Q LOSS MUTATED | 7 | 4 | 9 | 8 |
16Q LOSS WILD-TYPE | 447 | 99 | 181 | 96 |
P value = 0.00029 (Fisher's exact test), Q value = 0.0022
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
16Q LOSS MUTATED | 8 | 4 | 12 | 4 |
16Q LOSS WILD-TYPE | 472 | 123 | 246 | 11 |
P value = 0.00028 (Fisher's exact test), Q value = 0.0022
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
16Q LOSS MUTATED | 9 | 6 | 2 |
16Q LOSS WILD-TYPE | 314 | 38 | 4 |
P value = 0.00397 (Wilcoxon-test), Q value = 0.021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
17P LOSS MUTATED | 110 | 56.4 (14.7) |
17P LOSS WILD-TYPE | 766 | 60.7 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
17P LOSS MUTATED | 33 | 30 | 24 | 20 |
17P LOSS WILD-TYPE | 421 | 73 | 166 | 84 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
17P LOSS MUTATED | 34 | 33 | 41 | 3 |
17P LOSS WILD-TYPE | 446 | 94 | 217 | 12 |
P value = 5e-04 (Fisher's exact test), Q value = 0.0036
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
17P LOSS MUTATED | 55 | 4 | 5 |
17P LOSS WILD-TYPE | 268 | 40 | 1 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
17P LOSS MUTATED | 50 | 47 | 14 |
17P LOSS WILD-TYPE | 16 | 481 | 274 |
P value = 0.00889 (logrank test), Q value = 0.04
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
17Q LOSS MUTATED | 81 | 17 | 0.4 - 153.7 (59.1) |
17Q LOSS WILD-TYPE | 795 | 211 | 0.1 - 194.8 (32.6) |
P value = 0.000456 (Wilcoxon-test), Q value = 0.0033
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
17Q LOSS MUTATED | 82 | 54.8 (14.9) |
17Q LOSS WILD-TYPE | 794 | 60.7 (12.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
17Q LOSS MUTATED | 24 | 27 | 17 | 12 |
17Q LOSS WILD-TYPE | 430 | 76 | 173 | 92 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
17Q LOSS MUTATED | 25 | 29 | 26 | 2 |
17Q LOSS WILD-TYPE | 455 | 98 | 232 | 13 |
P value = 0.0283 (Wilcoxon-test), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
17Q LOSS MUTATED | 10 | 98.0 (4.2) |
17Q LOSS WILD-TYPE | 133 | 86.9 (23.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
17Q LOSS MUTATED | 50 | 29 | 3 |
17Q LOSS WILD-TYPE | 16 | 499 | 285 |
P value = 0.0654 (Fisher's exact test), Q value = 0.19
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
17Q LOSS MUTATED | 0 | 3 | 5 | 71 |
17Q LOSS WILD-TYPE | 2 | 13 | 116 | 648 |
P value = 5.07e-08 (logrank test), Q value = 8.3e-06
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
18P LOSS MUTATED | 139 | 58 | 0.4 - 123.6 (25.7) |
18P LOSS WILD-TYPE | 737 | 170 | 0.1 - 194.8 (37.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
18P LOSS MUTATED | 45 | 10 | 50 | 31 |
18P LOSS WILD-TYPE | 409 | 93 | 140 | 73 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
18P LOSS MUTATED | 48 | 15 | 71 | 7 |
18P LOSS WILD-TYPE | 432 | 112 | 187 | 8 |
P value = 0.0152 (Fisher's exact test), Q value = 0.061
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
18P LOSS MUTATED | 53 | 13 | 3 |
18P LOSS WILD-TYPE | 270 | 31 | 3 |
P value = 0.0239 (Fisher's exact test), Q value = 0.09
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
18P LOSS MUTATED | 89 | 24 |
18P LOSS WILD-TYPE | 457 | 65 |
P value = 0.073 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
18P LOSS MUTATED | 7 | 1983.1 (12.8) |
18P LOSS WILD-TYPE | 67 | 1972.7 (16.0) |
P value = 5.6e-07 (logrank test), Q value = 8e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
18Q LOSS MUTATED | 146 | 59 | 0.4 - 123.6 (27.0) |
18Q LOSS WILD-TYPE | 730 | 169 | 0.1 - 194.8 (37.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
18Q LOSS MUTATED | 50 | 11 | 51 | 31 |
18Q LOSS WILD-TYPE | 404 | 92 | 139 | 73 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
18Q LOSS MUTATED | 54 | 17 | 70 | 7 |
18Q LOSS WILD-TYPE | 426 | 110 | 188 | 8 |
P value = 0.00366 (Fisher's exact test), Q value = 0.02
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
18Q LOSS MUTATED | 57 | 16 | 3 |
18Q LOSS WILD-TYPE | 266 | 28 | 3 |
P value = 0.0378 (Fisher's exact test), Q value = 0.13
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
18Q LOSS MUTATED | 93 | 24 |
18Q LOSS WILD-TYPE | 453 | 65 |
P value = 0.059 (Fisher's exact test), Q value = 0.18
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 16 | 121 | 719 |
18Q LOSS MUTATED | 0 | 6 | 14 | 125 |
18Q LOSS WILD-TYPE | 2 | 10 | 107 | 594 |
P value = 5.51e-05 (logrank test), Q value = 0.00049
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
19P LOSS MUTATED | 29 | 14 | 0.9 - 109.9 (19.3) |
19P LOSS WILD-TYPE | 847 | 214 | 0.1 - 194.8 (36.5) |
P value = 0.0012 (Fisher's exact test), Q value = 0.0075
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
19P LOSS MUTATED | 7 | 1 | 13 | 6 |
19P LOSS WILD-TYPE | 447 | 102 | 177 | 98 |
P value = 0.00064 (Fisher's exact test), Q value = 0.0044
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
19P LOSS MUTATED | 9 | 2 | 15 | 3 |
19P LOSS WILD-TYPE | 471 | 125 | 243 | 12 |
P value = 0.025 (Fisher's exact test), Q value = 0.093
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
19P LOSS MUTATED | 8 | 4 | 1 |
19P LOSS WILD-TYPE | 315 | 40 | 5 |
P value = 0.043 (Fisher's exact test), Q value = 0.14
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
19P LOSS MUTATED | 1 | 12 | 16 |
19P LOSS WILD-TYPE | 65 | 516 | 272 |
P value = 0.000207 (logrank test), Q value = 0.0017
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
19Q LOSS MUTATED | 23 | 10 | 0.9 - 96.6 (16.9) |
19Q LOSS WILD-TYPE | 853 | 218 | 0.1 - 194.8 (36.5) |
P value = 0.00031 (Fisher's exact test), Q value = 0.0023
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
19Q LOSS MUTATED | 4 | 1 | 11 | 6 |
19Q LOSS WILD-TYPE | 450 | 102 | 179 | 98 |
P value = 2e-05 (Fisher's exact test), Q value = 2e-04
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
19Q LOSS MUTATED | 5 | 1 | 14 | 3 |
19Q LOSS WILD-TYPE | 475 | 126 | 244 | 12 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00045
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
19Q LOSS MUTATED | 3 | 5 | 2 |
19Q LOSS WILD-TYPE | 320 | 39 | 4 |
P value = 0.0881 (Fisher's exact test), Q value = 0.24
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
19Q LOSS MUTATED | 5 | 3 |
19Q LOSS WILD-TYPE | 541 | 86 |
P value = 5e-04 (Fisher's exact test), Q value = 0.0036
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
19Q LOSS MUTATED | 3 | 5 | 15 |
19Q LOSS WILD-TYPE | 63 | 523 | 273 |
P value = 0.00678 (Fisher's exact test), Q value = 0.032
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
20P LOSS MUTATED | 4 | 7 | 1 |
20P LOSS WILD-TYPE | 62 | 521 | 287 |
P value = 0.0873 (Fisher's exact test), Q value = 0.24
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
20Q LOSS MUTATED | 2 | 0 | 1 |
20Q LOSS WILD-TYPE | 321 | 44 | 5 |
P value = 0.00764 (Fisher's exact test), Q value = 0.035
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
20Q LOSS MUTATED | 3 | 3 | 0 |
20Q LOSS WILD-TYPE | 63 | 525 | 288 |
P value = 0.0633 (Fisher's exact test), Q value = 0.19
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
20Q LOSS MUTATED | 1 | 0 |
20Q LOSS WILD-TYPE | 41 | 622 |
P value = 0.0543 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
21Q LOSS MUTATED | 132 | 57.9 (13.5) |
21Q LOSS WILD-TYPE | 744 | 60.5 (12.3) |
P value = 0.00051 (Fisher's exact test), Q value = 0.0036
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
21Q LOSS MUTATED | 47 | 20 | 39 | 22 |
21Q LOSS WILD-TYPE | 407 | 83 | 151 | 82 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
21Q LOSS MUTATED | 48 | 24 | 55 | 6 |
21Q LOSS WILD-TYPE | 432 | 103 | 203 | 9 |
P value = 0.00165 (Fisher's exact test), Q value = 0.0098
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
21Q LOSS MUTATED | 50 | 13 | 4 |
21Q LOSS WILD-TYPE | 273 | 31 | 2 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
21Q LOSS MUTATED | 35 | 55 | 43 |
21Q LOSS WILD-TYPE | 31 | 473 | 245 |
P value = 0.0566 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 1973.7 (16.0) |
21Q LOSS MUTATED | 10 | 1982.2 (12.9) |
21Q LOSS WILD-TYPE | 64 | 1972.4 (16.1) |
P value = 0.00104 (logrank test), Q value = 0.0068
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 876 | 228 | 0.1 - 194.8 (35.9) |
22Q LOSS MUTATED | 106 | 38 | 0.9 - 152.0 (26.6) |
22Q LOSS WILD-TYPE | 770 | 190 | 0.1 - 194.8 (37.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
22Q LOSS MUTATED | 34 | 10 | 39 | 20 |
22Q LOSS WILD-TYPE | 420 | 93 | 151 | 84 |
P value = 0.00033 (Fisher's exact test), Q value = 0.0025
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
22Q LOSS MUTATED | 41 | 14 | 51 | 1 |
22Q LOSS WILD-TYPE | 439 | 113 | 207 | 14 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
22Q LOSS MUTATED | 33 | 16 | 3 |
22Q LOSS WILD-TYPE | 290 | 28 | 3 |
P value = 0.0269 (Fisher's exact test), Q value = 0.099
nPatients | 0 | 1 |
---|---|---|
ALL | 546 | 89 |
22Q LOSS MUTATED | 53 | 16 |
22Q LOSS WILD-TYPE | 493 | 73 |
P value = 0.0279 (Fisher's exact test), Q value = 0.1
nPatients | FEMALE | MALE |
---|---|---|
ALL | 292 | 590 |
22Q LOSS MUTATED | 46 | 61 |
22Q LOSS WILD-TYPE | 246 | 529 |
P value = 0.00464 (Wilcoxon-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 87.7 (22.8) |
22Q LOSS MUTATED | 25 | 72.8 (35.9) |
22Q LOSS WILD-TYPE | 118 | 90.8 (17.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
22Q LOSS MUTATED | 8 | 39 | 60 |
22Q LOSS WILD-TYPE | 58 | 489 | 228 |
P value = 0.0281 (Fisher's exact test), Q value = 0.1
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 622 |
22Q LOSS MUTATED | 10 | 72 |
22Q LOSS WILD-TYPE | 32 | 550 |
P value = 0.000515 (Wilcoxon-test), Q value = 0.0036
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
XP LOSS MUTATED | 113 | 55.7 (14.3) |
XP LOSS WILD-TYPE | 763 | 60.8 (12.1) |
P value = 0.00022 (Fisher's exact test), Q value = 0.0018
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
XP LOSS MUTATED | 38 | 22 | 34 | 14 |
XP LOSS WILD-TYPE | 416 | 81 | 156 | 90 |
P value = 6e-05 (Fisher's exact test), Q value = 0.00053
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
XP LOSS MUTATED | 40 | 25 | 47 | 2 |
XP LOSS WILD-TYPE | 440 | 102 | 211 | 13 |
P value = 0.00384 (Fisher's exact test), Q value = 0.02
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
XP LOSS MUTATED | 39 | 13 | 2 |
XP LOSS WILD-TYPE | 284 | 31 | 4 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
XP LOSS MUTATED | 38 | 44 | 32 |
XP LOSS WILD-TYPE | 28 | 484 | 256 |
P value = 0.00171 (Wilcoxon-test), Q value = 0.01
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 876 | 60.1 (12.5) |
XQ LOSS MUTATED | 112 | 56.0 (14.4) |
XQ LOSS WILD-TYPE | 764 | 60.8 (12.1) |
P value = 0.00039 (Fisher's exact test), Q value = 0.0029
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 454 | 103 | 190 | 104 |
XQ LOSS MUTATED | 38 | 21 | 33 | 16 |
XQ LOSS WILD-TYPE | 416 | 82 | 157 | 88 |
P value = 0.00015 (Fisher's exact test), Q value = 0.0012
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 480 | 127 | 258 | 15 |
XQ LOSS MUTATED | 40 | 23 | 46 | 4 |
XQ LOSS WILD-TYPE | 440 | 104 | 212 | 11 |
P value = 0.00634 (Fisher's exact test), Q value = 0.031
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 323 | 44 | 6 |
XQ LOSS MUTATED | 41 | 13 | 2 |
XQ LOSS WILD-TYPE | 282 | 31 | 4 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00012
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 528 | 288 |
XQ LOSS MUTATED | 38 | 45 | 30 |
XQ LOSS WILD-TYPE | 28 | 483 | 258 |
-
Copy number data file = broad_values_by_arm.txt from GISTIC pipeline
-
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/KIPAN-TP/22533780/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/KIPAN-TP/22506733/KIPAN-TP.merged_data.txt
-
Number of patients = 882
-
Number of significantly arm-level cnvs = 82
-
Number of selected clinical features = 14
-
Exclude regions that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.